CK1G2
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A5A3E0 | S1068 | Sugiyama | POTEF A26C1B | SLSTFQQMWISKQEyDEsGPsIVHRKCL_____________ |
| A6NMY6 | S127 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | AQyDAsELKAsMKGLGtDEDsLIEIICsRtNQELQEINRVy |
| A6NMY6 | T123 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | LKtPAQyDAsELKAsMKGLGtDEDsLIEIICsRtNQELQEI |
| O00165 | S189 | Sugiyama | HAX1 HS1BP1 | FDDVWPMDPHPRtREDNDLDsQVsQEGLGPVLQPQPKSYFK |
| O00165 | S192 | Sugiyama | HAX1 HS1BP1 | VWPMDPHPRtREDNDLDsQVsQEGLGPVLQPQPKSYFKsIS |
| O00566 | S171 | Sugiyama | MPHOSPH10 MPP10 | RAENSSKsDLRKsPVFsDEDsDLDFDISKLEQQSKVQNKGQ |
| O00571 | S70 | Sugiyama | DDX3X DBX DDX3 | KGFyDKDSSGWsssKDKDAyssFGsRsDsRGKssFFsDRGs |
| O14602 | S102 | Sugiyama | EIF1AY | RDYQDNKADVILKYNADEARsLKAyGELPEHAKINETDTFG |
| O14654 | S859 | SIGNOR|PSP | IRS4 | RGLDKEVSyNWDPKDAASKPsGEGsFSKPGDGGsPsKPSDH |
| O14980 | S450 | Sugiyama | XPO1 CRM1 | VLVVENDQGEVVREFMKDTDsINLyKNMRETLVyLTHLDyV |
| O15226 | S532 | Sugiyama | NKRF ITBA4 NRF | KKTQPTVINNLKKGAVEDVIsRNEIQGRSAEEAYKQQIKED |
| O15230 | S1611 | Sugiyama | LAMA5 KIAA0533 KIAA1907 | PLTGQCYCKENVQGPKCDQCsLGTFsLDAANPKGCTRCFCF |
| O15230 | S1616 | Sugiyama | LAMA5 KIAA0533 KIAA1907 | CYCKENVQGPKCDQCsLGTFsLDAANPKGCTRCFCFGATER |
| O15523 | S70 | Sugiyama | DDX3Y DBY | KGFHDKDSSGWSCSKDKDAyssFGsRDSRGKPGYFSERGSG |
| O43707 | T445 | Sugiyama | ACTN4 | HEAWtDGKEAMLKHRDyEtAtLsDIKALIRKHEAFEsDLAA |
| O43815 | S229 | Sugiyama | STRN | TEAEVKETAMIAKSELtDsAsVLDNFKFLEsAAADFsDEDE |
| O43823 | S124 | Sugiyama | AKAP8 AKAP95 | SKEGGRGGsGGGGEGIQDREssFRFQPFESYDSRPCLPEHN |
| O43847 | S96 | Sugiyama | NRDC NRD1 | SRVARLGADEsEEEGRRGsLsNAGDPEIVKsPsDPKQYRYI |
| O43852 | S261 | Sugiyama | CALU | RDKNRDGKMDKEEtKDWILPsDyDHAEAEARHLVyEsDQNK |
| O43852 | S300 | Sugiyama | CALU | NKDGKLTKEEIVDKyDLFVGsQAtDFGEALVRHDEF_____ |
| O43852 | S44 | Sugiyama | CALU | KKDRVHHEPQLsDKVHNDAQsFDyDHDAFLGAEEAKtFDQL |
| O43852 | T303 | Sugiyama | CALU | GKLTKEEIVDKyDLFVGsQAtDFGEALVRHDEF________ |
| O60264 | S825 | Sugiyama | SMARCA5 SNF2H WCRF135 | ELPNAAQAQKEEQLKIDEAEsLNDEELEEKEKLLTQGFTNW |
| O60664 | S225 | Sugiyama | PLIN3 M6PRBP1 TIP47 | PLTDAELARIAtsLDGFDVAsVQQQRQEQSyFVRLGsLSER |
| O60701 | S392 | Sugiyama | UGDH | PREQIVVDLsHPGVSEDDQVsRLVTISKDPYEACDGAHAVV |
| O60763 | S952 | Sugiyama | USO1 VDP | HPVEEEDELEsGDQEDEDDEsEDPGKDLDHI__________ |
| O75400 | S935 | Sugiyama | PRPF40A FBP11 FLAF1 FNBP3 HIP10 HYPA HSPC225 | KHKSPKKKtGKDsGNWDtsGsELsEGELEKRRRtLLEQLDD |
| O75400 | S938 | Sugiyama | PRPF40A FBP11 FLAF1 FNBP3 HIP10 HYPA HSPC225 | SPKKKtGKDsGNWDtsGsELsEGELEKRRRtLLEQLDDDQ_ |
| O75821 | T240 | Sugiyama | EIF3G EIF3S4 | DGAsRRGESMQPNRRADDNAtIRVtNLSEDTRETDLQELFR |
| O95218 | S181 | Sugiyama | ZRANB2 ZIS ZNF265 | DEDLsKyKLDEDEDEDDADLsKyNLDAsEEEDsNKKKSNRR |
| O95714 | S2928 | Sugiyama | HERC2 | ILLGRIRAEEEDLAAVPFLAsDNEEEEDEKGNSGsLIRKKA |
| P00558 | S390 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | IIGGGDtAtCCAKWNtEDKVsHVstGGGAsLELLEGKVLPG |
| P00558 | S393 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | GGDtAtCCAKWNtEDKVsHVstGGGAsLELLEGKVLPGVDA |
| P02545 | S282 | Sugiyama | LMNA LMN1 | ELEKTYSAKLDNARQsAERNsNLVGAAHEELQQsRIRIDsL |
| P04040 | T441 | Sugiyama | CAT | HSIQYSGEVRRFNtANDDNVtQVRAFyVNVLNEEQRKRLCE |
| P04075 | S336 | Sugiyama | ALDOA ALDA | GKKENLKAAQEEYVKRALANsLACQGKytPsGQAGAAAsEs |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | S46 | Sugiyama | ALDOA ALDA | PGKGILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtA |
| P04083 | S189 | Sugiyama | ANXA1 ANX1 LPC1 | tsDtsGDFRNALLsLAKGDRsEDFGVNEDLADsDARALyEA |
| P05023 | S217 | Sugiyama | ATP1A1 | DRIPADLRIIsANGCKVDNssLtGESEPQtRsPDFtNENPL |
| P05386 | S101 | Sugiyama | RPLP1 RRP1 | APstAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD_______ |
| P05387 | S102 | Sugiyama | RPLP2 D11S2243E RPP2 | PAAGsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD_______ |
| P05455 | S225 | Sugiyama | SSB | LRAKQEQEAKQKLEEDAEMKsLEEKIGCLLKFSGDLDDQTC |
| P05455 | S325 | Sugiyama | SSB | VLEGEVEKEALKKIIEDQQEsLNKWKSKGRRFKGKGKGNKA |
| P05787 | S258 | Sugiyama | KRT8 CYK8 | QISDTSVVLsMDNSRsLDMDsIIAEVKAQyEDIANRsRAEA |
| P05787 | S280 | Sugiyama | KRT8 CYK8 | IAEVKAQyEDIANRsRAEAEsMyQIKyEELQsLAGKHGDDL |
| P05787 | S291 | Sugiyama | KRT8 CYK8 | ANRsRAEAEsMyQIKyEELQsLAGKHGDDLRRTKTEISEMN |
| P07205 | S390 | Sugiyama | PGK2 PGKB | VIGGGDTATCCAKWNtEDKVsHVstGGGAsLELLEGKILPG |
| P07205 | S393 | Sugiyama | PGK2 PGKB | GGDTATCCAKWNtEDKVsHVstGGGAsLELLEGKILPGVEA |
| P07355 | S127 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | AQyDAsELKAsMKGLGtDEDsLIEIICsRtNQELQEINRVy |
| P07355 | S184 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | sGDFRKLMVALAKGRRAEDGsVIDyELIDQDARDLyDAGVK |
| P07355 | T123 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | LKtPAQyDAsELKAsMKGLGtDEDsLIEIICsRtNQELQEI |
| P07737 | S30 | Sugiyama | PFN1 | NLMADGTCQDAAIVGYKDsPsVWAAVPGKtFVNITPAEVGV |
| P07814 | S739 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | TKVEATKNETSAPFKERPtPsLNNNCttsEDsLVLyNRVAV |
| P07900 | S476 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | RKKLsELLRyytsAsGDEMVsLKDYCTRMKENQKHIyyItG |
| P07900 | S543 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | EPIDEyCVQQLKEFEGKtLVsVTKEGLELPEDEEEKKKQEE |
| P07900 | T305 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IDQEELNKtKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLA |
| P07900 | T540 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | yMIEPIDEyCVQQLKEFEGKtLVsVTKEGLELPEDEEEKKK |
| P07942 | S449 | Sugiyama | LAMB1 | KLNVEGEHCDVCKEGFyDLssEDPFGCKSCACNPLGTIPGG |
| P07948 | S13 | SIGNOR|PSP | LYN JTK8 | ________MGCIKSKGKDsLsDDGVDLKTQPVRNTERTIyV |
| P08238 | S468 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | RRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItG |
| P08238 | T297 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IDQEELNKtKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLA |
| P08670 | S214 | Sugiyama | VIM | LQREEAENtLQsFRQDVDNAsLARLDLERKVEsLQEEIAFL |
| P09382 | T58 | Sugiyama | LGALS1 | DsNNLCLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVF |
| P0CAP2 | S187 | Sugiyama | POLR2M GRINL1A | EASEHHPRHRVssQAEDtSssFDNLFIDRLQRITIADQGEQ |
| P0CG38 | S1068 | Sugiyama | POTEI | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG39 | S1031 | Sugiyama | POTEJ | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P11047 | S942 | Sugiyama | LAMC1 LAMB2 | GFYNLQSGQGCERCDCHALGstNGQCDIRTGQCECQPGITG |
| P11142 | S221 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | GGGTFDVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVNHF |
| P11142 | T163 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VVtVPAyFNDsQRQAtKDAGtIAGLNVLRIINEPtAAAIAy |
| P11586 | S129 | Sugiyama | MTHFD1 MTHFC MTHFD | INTEEVINAIAPEKDVDGLtsINAGKLARGDLNDCFIPCtP |
| P13489 | S290 | Sugiyama | RNH1 PRI RNH | AKGCGDLCRVLRAKESLKELsLAGNELGDEGARLLCETLLE |
| P13637 | S207 | Sugiyama | ATP1A3 | DRVPADLRIISAHGCKVDNssLtGESEPQTRSPDCTHDNPL |
| P13639 | S38 | Sugiyama | EEF2 EF2 | NIRNMsVIAHVDHGKStLtDsLVCKAGIIAsARAGEtRFtD |
| P13667 | S126 | Sugiyama | PDIA4 ERP70 ERP72 | NILKDKDPPIPVAKIDAtsAsVLAsRFDVsGyPtIKILKKG |
| P13861 | S80 | Sugiyama | PRKAR2A PKR2 PRKAR2 | GHPPPEPGPDRVADAKGDsEsEEDEDLEVPVPsRFNRRVsV |
| P14314 | S126 | Sugiyama | PRKCSH G19P1 | yNsGVICENtCKEKGRKEREsLQQMAEVtREGFRLKKILIE |
| P14625 | S523 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | RtRLAKLLRFQssHHPtDItsLDQyVERMKEKQDKIyFMAG |
| P18084 | S507 | Sugiyama | ITGB5 | CECSPGYLGTRCECQDGENQsVyQNLCREAEGKPLCSGRGD |
| P19338 | S458 | Sugiyama | NCL | TEADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKN |
| P19338 | S460 | Sugiyama | NCL | ADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNST |
| P19338 | Y462 | Sugiyama | NCL | AEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNSTWs |
| P19838 | S923 | Sugiyama | NFKB1 | sLPLsPAstRQQIDELRDSDsVCDsGVEtsFRKLsFtEsLt |
| P20648 | S228 | Sugiyama | ATP4A | DRVPADIRILAAQGCKVDNssLtGESEPQTRSPECTHESPL |
| P20810 | S311 | Sugiyama | CAST | LEALsAsLGTRQAEPELDLRsIKEVDEAKAKEEKLEKCGED |
| P20810 | S373 | Sugiyama | CAST | LPEPEEKPKPRsEsELIDELsEDFDRsECKEKPSKPTEKTE |
| P22059 | S190 | Sugiyama | OSBP OSBP1 | QRWVTALELAKAKAVKMLAEsDEsGDEEsVsQtDKTELQNT |
| P22059 | S193 | Sugiyama | OSBP OSBP1 | VTALELAKAKAVKMLAEsDEsGDEEsVsQtDKTELQNTLRT |
| P25205 | S704 | Sugiyama | MCM3 | DQEQKRKRRKTRQPDAKDGDsyDPyDFsDtEEEMPQVHtPK |
| P25705 | S53 | Sugiyama | ATP5F1A ATP5A ATP5A1 ATP5AL2 ATPM | ARNFHASNTHLQKtGtAEMssILEERILGADtsVDLEETGR |
| P25788 | S243 | Sugiyama | PSMA3 HC8 PSC8 | GRHEIVPKDIREEAEKyAKEsLKEEDEsDDDNM________ |
| P25788 | Y239 | Sugiyama | PSMA3 HC8 PSC8 | ELTNGRHEIVPKDIREEAEKyAKEsLKEEDEsDDDNM____ |
| P26038 | S576 | Sugiyama | MSN | YKtLRQIRQGNTKQRIDEFEsM___________________ |
| P26641 | S304 | Sugiyama | EEF1G EF1G PRO1608 | PKstFVLDEFKRKysNEDtLsVALPyFWEHFDKDGWSLWyS |
| P26641 | T302 | Sugiyama | EEF1G EF1G PRO1608 | HLPKstFVLDEFKRKysNEDtLsVALPyFWEHFDKDGWSLW |
| P27797 | S195 | Sugiyama | CALR CRTC | IVRPDNtyEVKIDNsQVEsGsLEDDWDFLPPKKIKDPDAsK |
| P29401 | S295 | Sugiyama | TKT | ysQIQsKKKILAtPPQEDAPsVDIANIRMPsLPsyKVGDKI |
| P30041 | S186 | Sugiyama | PRDX6 AOP2 KIAA0106 | SLQLTAEKRVAtPVDWKDGDsVMVLPtIPEEEAKKLFPKGV |
| P30043 | T199 | Sugiyama | BLVRB FLR SCAN | HDLGHFMLRCLttDEyDGHstyPsHQyQ_____________ |
| P31150 | S316 | Sugiyama | GDI1 GDIL OPHN2 RABGDIA XAP4 | QVIRIICILSHPIKNtNDANsCQIIIPQNQVNRKSDIYVCM |
| P31327 | S1021 | Sugiyama | CPS1 | RTLRQLGKKTVVVNCNPETVstDFDECDKLyFEELSLERIL |
| P31327 | S1090 | Sugiyama | CPS1 | KNGVKIMGTsPLQIDRAEDRsIFsAVLDELKVAQAPWKAVN |
| P31327 | S1093 | Sugiyama | CPS1 | VKIMGTsPLQIDRAEDRsIFsAVLDELKVAQAPWKAVNTLN |
| P31327 | S564 | Sugiyama | CPS1 | TEDRQLFSDKLNEINEKIAPsFAVEsIEDALKAADTIGyPV |
| P31327 | S569 | Sugiyama | CPS1 | LFSDKLNEINEKIAPsFAVEsIEDALKAADTIGyPVMIRSA |
| P31327 | S863 | Sugiyama | CPS1 | LSEPSsTRIyAIAKAIDDNMsLDEIEKLTYIDKWFLYKMRD |
| P31943 | S281 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | GRDLNyCFsGMsDHRyGDGGstFQsttGHCVHMRGLPYRAt |
| P34932 | T649 | Sugiyama | HSPA4 APG2 HSPH2 | RDKLSGEYEKFVSEDDRNsFtLKLEDTENWLyEDGEDQPKQ |
| P35579 | S169 | Sugiyama | MYH9 | HIyAITDtAyRSMMQDREDQsILCTGESGAGKTENTKKVIQ |
| P35580 | S1013 | Sugiyama | MYH10 | QNSKFIKEKKLMEDRIAECssQLAEEEEKAKNLAKIRNKQE |
| P35580 | S1312 | Sugiyama | MYH10 | VsTLLEEAEKKGIKFAKDAAsLEsQLQDtQELLQEETRQKL |
| P35580 | S1315 | Sugiyama | MYH10 | LLEEAEKKGIKFAKDAAsLEsQLQDtQELLQEETRQKLNLS |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P40337 | S72 | Sugiyama | VHL | EEMEAGRPRPVLRSVNsREPsQVIFCNRsPRVVLPVWLNFD |
| P40925 | S326 | Sugiyama | MDH1 MDHA | NDFSREKMDLTAKELtEEKEsAFEFLssA____________ |
| P40925 | S332 | Sugiyama | MDH1 MDHA | KMDLTAKELtEEKEsAFEFLssA__________________ |
| P42696 | S90 | Sugiyama | RBM34 KIAA0117 | VYVPVPKQTIKKTKRNEEEEstsQIERPLsQEPAKKVKAKK |
| P42696 | S92 | Sugiyama | RBM34 KIAA0117 | VPVPKQTIKKTKRNEEEEstsQIERPLsQEPAKKVKAKKKH |
| P43034 | S152 | Sugiyama | PAFAH1B1 LIS1 MDCR MDS PAFAHA | IKVWDyEtGDFERtLKGHtDsVQDIsFDHsGKLLASCSADM |
| P43487 | S188 | Sugiyama | RANBP1 | KAGSGKNDHAEKVAEKLEALsVKEETKEDAEEKQ_______ |
| P45974 | S783 | Sugiyama | USP5 ISOT | IDDLDAEAAMDISEGRsAADsIsEsVPVGPKVRDGPGKYQL |
| P47712 | S454 | Sugiyama | PLA2G4A CPLA2 PLA2G4 | ssDsDDEsHEPKGtENEDAGsDyQsDNQASWIHRMIMALVS |
| P47756 | S204 | Sugiyama | CAPZB | sGtMNLGGsLtRQMEKDEtVsDCsPHIANIGRLVEDMENKI |
| P47813 | S102 | Sugiyama | EIF1AX EIF1A EIF4C | RDYQDNKADVILKYNADEARsLKAyGELPEHAKINETDTFG |
| P48643 | S270 | Sugiyama | CCT5 CCTE KIAA0098 | ILTCPFEPPKPKTKHKLDVtsVEDyKALQKYEKEKFEEMIQ |
| P49327 | S2198 | Sugiyama | FASN FAS | EVRQLTLRKLQELSSKADEAsELACPtPKEDGLAQQQtQLN |
| P49368 | T486 | Sugiyama | CCT3 CCTG TRIC5 | LRAKHtQENCEtWGVNGEtGtLVDMKELGIWEPLAVKLQTY |
| P49792 | S2493 | Sugiyama | RANBP2 NUP358 | EEtTRERTDVIQGDDVADAtsEVEVsstSEttPKAVVsPPK |
| P50395 | S316 | Sugiyama | GDI2 RABGDIB | QVIRVICILSHPIKNtNDANsCQIIIPQNQVNRKSDIyVCM |
| P50993 | S215 | Sugiyama | ATP1A2 KIAA0778 | DRVPADLRIISSHGCKVDNssLtGESEPQTRSPEFTHENPL |
| P51116 | S601 | Sugiyama | FXR2 FMR1L2 | RPQRRNRSRRRRNRGNRtDGsIsGDRQPVtVADyIsRAEsQ |
| P51532 | S699 | Sugiyama | SMARCA4 BAF190A BRG1 SNF2B SNF2L4 | PPTLPVEEKKKIPDPDsDDVsEVDARHIIENAKQDVDDEyG |
| P53999 | S19 | Sugiyama | SUB1 PC4 RPO2TC1 | __MPKSKELVsssssGsDsDsEVDKKLKRKKQVAPEKPVKK |
| P54105 | S210 | Sugiyama | CLNS1A CLCI ICLN | GMLsQsVssQYNMAGVRtEDsIRDyEDGMEVDttPtVAGQF |
| P54577 | S386 | Sugiyama | YARS1 YARS | sRLDIRVGKIITVEKHPDADsLyVEKIDVGEAEPRTVVSGL |
| P54652 | S224 | Sugiyama | HSPA2 | GGGTFDVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVSHL |
| P55036 | S266 | Sugiyama | PSMD4 MCB1 | AGIATTGtEDsDDALLKMtIsQQEFGRTGLPDLSSMTEEEQ |
| P55072 | S197 | Sugiyama | VCP HEL-220 HEL-S-70 | APDTVIHCEGEPIKREDEEEsLNEVGyDDIGGCRKQLAQIK |
| P55854 | S27 | Sugiyama | SUMO3 SMT3A SMT3H1 | KEGVKTENDHINLKVAGQDGsVVQFKIKRHTPLSKLMKAYC |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60709 | S323 | Sugiyama | ACTB | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P60709 | S368 | Sugiyama | ACTB | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P60709 | S60 | Sugiyama | ACTB | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P60709 | T324 | Sugiyama | ACTB | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P60709 | Y53 | Sugiyama | ACTB | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P61247 | S236 | Sugiyama | RPS3A FTE1 MFTL | KMLKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGy |
| P61916 | S29 | Sugiyama | NPC2 HE1 | LLLALSTAAQAEPVQFKDCGsVDGVIKEVNVsPCPtQPCQL |
| P61956 | S28 | Sugiyama | SUMO2 SMT3B SMT3H2 | EGVKtENNDHINLKVAGQDGsVVQFKIKRHTPLSKLMKAYC |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62258 | S148 | Sugiyama | YWHAE | YHRyLAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHP |
| P62736 | S325 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62736 | S62 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P62736 | T326 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P62736 | Y55 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P62857 | T57 | Sugiyama | RPS28 | DtsRsIIRNVKGPVREGDVLtLLEsEREARRLR________ |
| P62873 | S31 | Sugiyama | GNB1 | AEQLKNQIRDARKACADAtLsQItNNIDPVGRIQMRTRRTL |
| P62873 | T34 | Sugiyama | GNB1 | LKNQIRDARKACADAtLsQItNNIDPVGRIQMRTRRTLRGH |
| P63104 | S28 | Sugiyama | YWHAZ | QKAKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAy |
| P63104 | T30 | Sugiyama | YWHAZ | AKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAyKN |
| P63167 | T26 | Sugiyama | DYNLL1 DLC1 DNCL1 DNCLC1 HDLC1 | AVIKNADMsEEMQQDsVECAtQALEKYNIEKDIAAHIKKEF |
| P63220 | S68 | Sugiyama | RPS21 | GQFKtyAICGAIRRMGEsDDsILRLAKADGIVSKNF_____ |
| P63261 | S323 | Sugiyama | ACTG1 ACTG | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P63261 | S368 | Sugiyama | ACTG1 ACTG | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63261 | S60 | Sugiyama | ACTG1 ACTG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P63261 | T324 | Sugiyama | ACTG1 ACTG | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P63261 | Y53 | Sugiyama | ACTG1 ACTG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P63267 | S324 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P63267 | S61 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P63267 | T325 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P63267 | Y54 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68032 | S325 | Sugiyama | ACTC1 ACTC | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68032 | S62 | Sugiyama | ACTC1 ACTC | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68032 | T326 | Sugiyama | ACTC1 ACTC | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68032 | Y55 | Sugiyama | ACTC1 ACTC | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68133 | S325 | Sugiyama | ACTA1 ACTA | TTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68133 | S62 | Sugiyama | ACTA1 ACTA | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68133 | T326 | Sugiyama | ACTA1 ACTA | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68133 | Y55 | Sugiyama | ACTA1 ACTA | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68363 | T73 | Sugiyama | TUBA1B | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| P68363 | Y83 | Sugiyama | TUBA1B | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| P78368 | S26 | Sugiyama | CSNK1G2 CK1G2 | KGGKGETEEGRRMSKAGGGRssHGIRssGTSSGVLMVGPNF |
| P78368 | S27 | Sugiyama | CSNK1G2 CK1G2 | GGKGETEEGRRMSKAGGGRssHGIRssGTSSGVLMVGPNFR |
| P78368 | S32 | Sugiyama | CSNK1G2 CK1G2 | TEEGRRMSKAGGGRssHGIRssGTSSGVLMVGPNFRVGKKI |
| P78368 | S33 | Sugiyama | CSNK1G2 CK1G2 | EEGRRMSKAGGGRssHGIRssGTSSGVLMVGPNFRVGKKIG |
| P78371 | S150 | Sugiyama | CCT2 99D8.1 CCTB | WREATKAAREALLssAVDHGsDEVKFRQDLMNIAGTTLssK |
| P84022 | S418 | SIGNOR|PSP | SMAD3 MADH3 | LHLNGPLQWLDKVLTQMGsPsIRCssVs_____________ |
| Q00839 | S59 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | QAALDDEEAGGRPAMEPGNGsLDLGGDsAGRSGAGLEQEAA |
| Q01082 | S2128 | Sugiyama | SPTBN1 SPTB2 | KVsEEAEsQQQWDtsKGEQVsQNGLPAEQGsPRMAETVDTs |
| Q01105 | S133 | Sugiyama | SET | DEEALHYLTRVEVtEFEDIKsGyRIDFyFDENPyFENKVLS |
| Q01105 | S165 | Sugiyama | SET | PyFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQ |
| Q01105 | S168 | Sugiyama | SET | ENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQTQN |
| Q01105 | T169 | Sugiyama | SET | NKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQTQNK |
| Q04917 | T31 | Sugiyama | YWHAH YWHA1 | ARLAEQAERyDDMAsAMKAVtELNEPLsNEDRNLLsVAyKN |
| Q06830 | S126 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | SDPKRtIAQDyGVLKADEGIsFRGLFIIDDKGILRQItVND |
| Q07157 | S1065 | Sugiyama | TJP1 ZO1 | YVEKQAsRDLEQPtyRyEsssytDQFsRNYEHRLRYEDRVP |
| Q07666 | S150 | Sugiyama | KHDRBS1 SAM68 | EKIQKGDSKKDDEENyLDLFsHKNMKLKERVLIPVKQYPKF |
| Q12802 | S1253 | Sugiyama | AKAP13 BRX HT31 LBC | MVSAQDAPLPKGADLIEEAAsRIVDAVIEQVKAAGALLtEG |
| Q12802 | S1507 | Sugiyama | AKAP13 BRX HT31 LBC | HGsDVSLSQILKPNRSRDRQsLDGFysHGMGAEGRESESEP |
| Q12805 | T219 | Sugiyama | EFEMP1 FBLN3 FBNL | CQCPPGYQKRGEQCVDIDECtIPPYCHQRCVNTPGSFYCQC |
| Q12888 | S598 | Sugiyama | TP53BP1 | QLsQNDDKtKGDDtDtRDDIsILATGCKGREETVAEDVCID |
| Q12906 | S190 | Sugiyama | ILF3 DRBF MPHOSPH4 NF90 | HLTSPVVREEMEKVLAGEtLsVNDPPDVLDRQKCLAALASL |
| Q13263 | S784 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | DVGRMFKQFNKLTEDKADVQsIIGLQRFFETRMNEAFGDTK |
| Q13541 | S112 | Sugiyama | EIF4EBP1 | EAsQsHLRNsPEDKRAGGEEsQFEMDI______________ |
| Q14151 | S234 | Sugiyama | SAFB2 KIAA0138 | EKILDILGEtCKsEPVKEEssELEQPFAQDtssVGPDRKLA |
| Q14151 | S246 | Sugiyama | SAFB2 KIAA0138 | sEPVKEEssELEQPFAQDtssVGPDRKLAEEEDLFDsAHPE |
| Q14152 | S584 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EHQRILARRQtIEERKERLEsLNIQREKEELEQREAELQKV |
| Q14152 | S988 | Sugiyama | EIF3A EIF3S10 KIAA0139 | PRRGPEEDRFsRRGADDDRPsWRNTDDDRPPRRIADEDRGN |
| Q14152 | T1378 | Sugiyama | EIF3A EIF3S10 KIAA0139 | AEKDREsLRRTKNEtDEDGWttVRR________________ |
| Q14203 | S417 | Sugiyama | DCTN1 | KKNQELEVVRQQRERLQEELsQAEstIDELKEQVDAALGAE |
| Q14444 | S97 | Sugiyama | CAPRIN1 GPIAP1 GPIP137 M11S1 RNG105 | DYQERMNKGERLNQDQLDAVsKyQEVtNNLEFAKELQRsFM |
| Q14457 | S409 | EPSD|PSP | BECN1 GT197 | RFCLPYRMDVEKGKIEDtGGsGGSYSIKTQFNSEEQWTKAL |
| Q14457 | T406 | EPSD|PSP | BECN1 GT197 | GEtRFCLPYRMDVEKGKIEDtGGsGGSYSIKTQFNSEEQWT |
| Q14498 | S334 | Sugiyama | RBM39 HCC1 RNPC2 | FELAGRPMKVGHVTERtDAssAssFLDsDELERtGIDLGtT |
| Q14498 | S337 | Sugiyama | RBM39 HCC1 RNPC2 | AGRPMKVGHVTERtDAssAssFLDsDELERtGIDLGtTGRL |
| Q14766 | S1414 | Sugiyama | LTBP1 | TAEFTEMCPKGKGFVPAGEsssEAGGENyKDADECLLFGQE |
| Q15181 | S127 | Sugiyama | PPA1 IOPPP PP | NDKHTGCCGDNDPIDVCEIGsKVCARGEIIGVKVLGILAMI |
| Q15185 | S118 | Sugiyama | PTGES3 P23 TEBP | WLsVDFNNWKDWEDDsDEDMsNFDRFSEMMNNMGGDEDVDL |
| Q15293 | T71 | Sugiyama | RCN1 RCN | EDNQsFQYDHEAFLGKEDsKtFDQLtPDEsKERLGKIVDRI |
| Q15424 | S235 | Sugiyama | SAFB HAP HET SAFB1 | EKILDILGEtCKsEPVKEEssELEQPFAQDtssVGPDRKLA |
| Q15424 | S247 | Sugiyama | SAFB HAP HET SAFB1 | sEPVKEEssELEQPFAQDtssVGPDRKLAEEEDLFDsAHPE |
| Q15758 | S539 | Sugiyama | SLC1A5 ASCT2 M7V1 RDR RDRC | PLLKHyRGPAGDAtVAsEKEsVM__________________ |
| Q16643 | S255 | Sugiyama | DBN1 D0S117E | HRRKQQTLEAEEAKRRLKEQsIFGDHRDEEEEtHMKKsEsE |
| Q16643 | T267 | Sugiyama | DBN1 D0S117E | AKRRLKEQsIFGDHRDEEEEtHMKKsEsEVEEAAAIIAQRP |
| Q32M45 | S843 | Sugiyama | ANO4 TMEM16D | VNASLSVFRISDFENRSEPEsDGSEFsGtPLKyCRYRDYRD |
| Q32M45 | S849 | Sugiyama | ANO4 TMEM16D | VFRISDFENRSEPEsDGSEFsGtPLKyCRYRDYRDPPHSLV |
| Q32M45 | T851 | Sugiyama | ANO4 TMEM16D | RISDFENRSEPEsDGSEFsGtPLKyCRYRDYRDPPHSLVPY |
| Q32MZ4 | S766 | Sugiyama | LRRFIP1 GCF2 TRIP | sTERCEMSEHPSQTVRKALDsNsLENDDLSAPGREPGHFNP |
| Q56P03 | S55 | Sugiyama | EAPP C14orf11 BM-036 | HGTPDQKRKLIRECLTGESEsssEDEFEKEMEAELNSTMKT |
| Q58FG1 | S251 | Sugiyama | HSP90AA4P HSP90AD HSPCAL2 | EPIDEYCVQQLKEFEGKtLVsVTKEDLELPEDEEEKKKQEE |
| Q58FG1 | T248 | Sugiyama | HSP90AA4P HSP90AD HSPCAL2 | YTIEPIDEYCVQQLKEFEGKtLVsVTKEDLELPEDEEEKKK |
| Q5JSH3 | S199 | Sugiyama | WDR44 RPH11 | EAVEVKGGGDVLEPVssDsLstKDFAAVEEVAPAKPPRHLt |
| Q5T035 | S66 | Sugiyama | FAM120A2P C9orf129 | LSEPAPLTLDTSGKNLtEQNsysNIPHEGKHtPLyERSLPI |
| Q5T4S7 | S2904 | Sugiyama | UBR4 KIAA0462 KIAA1307 RBAF600 | tsPADHGGsVGsEsGGsAVDsVAGEHsVsGRSSAYGDATAE |
| Q5UIP0 | S1693 | Sugiyama | RIF1 | NLRTRNAIKRLHKRDsFDNCsLGESSKIGIsDIssLsEKtF |
| Q6EEV6 | S28 | Sugiyama | SUMO4 SMT3H4 | EEVKTENNNHINLKVAGQDGsVVQFKIKRQTPLSKLMKAYC |
| Q6NZY4 | S605 | Sugiyama | ZCCHC8 | EIFTKKsEAGHAssPDsEVTsLCQKEKAELAPVNTEGALLD |
| Q6P996 | S718 | Sugiyama | PDXDC1 KIAA0251 | KQRLPGQKPFKRsLRGsDALsEtssVsHIEDLEKVERLssG |
| Q6P996 | S722 | Sugiyama | PDXDC1 KIAA0251 | PGQKPFKRsLRGsDALsEtssVsHIEDLEKVERLssGPEQI |
| Q6P996 | S779 | Sugiyama | PDXDC1 KIAA0251 | QHtDQtEAFQKGVPHPEDDHsQVEGPEsLR___________ |
| Q6PCE3 | S311 | Sugiyama | PGM2L1 BM32A | QKDPDPDFSTVKCPNPEEGEsVLELsLRLAEKENARVVLAT |
| Q6PKG0 | S627 | Sugiyama | LARP1 KIAA0731 LARP | FLFDEEMEQMDGRKNtFtAWsDEEsDyEIDDRDVNKILIVt |
| Q6PKG0 | S631 | Sugiyama | LARP1 KIAA0731 LARP | EEMEQMDGRKNtFtAWsDEEsDyEIDDRDVNKILIVtQtPH |
| Q6S8J3 | S1068 | Sugiyama | POTEE A26C1A POTE2 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q6ULP2 | S584 | Sugiyama | AFTPH AFTH | AGPSQVVDWNAFEDEQKDsCsWAAFGDQQATESHHRKEAWQ |
| Q6UN15 | S496 | Sugiyama | FIP1L1 FIP1 RHE | DRERERTRERERERDHsPtPsVFNsDEERyRYREYAERGYE |
| Q6UXH1 | S295 | Sugiyama | CRELD2 UNQ185/PRO211 | KECISGYAREHGQCADVDECsLAEKtCVRKNENCYNTPGSY |
| Q71U36 | T73 | Sugiyama | TUBA1A TUBA3 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q71U36 | Y83 | Sugiyama | TUBA1A TUBA3 | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| Q7KZF4 | S474 | Sugiyama | SND1 TDRD11 | LVSKGLATVIRYRQDDDQRssHyDELLAAEARAIKNGKGLH |
| Q7Z460 | S1216 | Sugiyama | CLASP1 KIAA0622 MAST1 | sQEDLNEPIKRDGKKECDIVsRDGGAAsPAtEGRGGsEVEG |
| Q7Z5K2 | S459 | Sugiyama | WAPL FOE KIAA0261 WAPAL | DEGGsGsSNYKIKyFGFDDLsEsEDDEDDDCQVERKTSKKR |
| Q86W56 | Y832 | Sugiyama | PARG | DDWQRRCTEIVAIDALHFRRyLDQFVPEKMRRELNKAYCGF |
| Q8IWS0 | S183 | Sugiyama | PHF6 CENP-31 KIAA1823 | RKGRPRKTNFKGLSEDtRstssHGtDEMEsssyRDRsPHRs |
| Q8IWS0 | S184 | Sugiyama | PHF6 CENP-31 KIAA1823 | KGRPRKTNFKGLSEDtRstssHGtDEMEsssyRDRsPHRss |
| Q8N6T3 | S348 | Sugiyama | ARFGAP1 ARF1GAP | FWETFGSAEPTKtRKsPssDsWtCADtstERRssDsWEVWG |
| Q8N6T3 | T350 | Sugiyama | ARFGAP1 ARF1GAP | ETFGSAEPTKtRKsPssDsWtCADtstERRssDsWEVWGSA |
| Q8NBJ7 | S283 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | GsANHRARVttRMGNtPDsAsDNLGFRCAADAGRPPGEL__ |
| Q8NBS9 | S129 | Sugiyama | TXNDC5 TLP46 UNQ364/PRO700 | MEDAKVYVAKVDCtAHsDVCsAQGVRGYPTLKLFKPGQEAV |
| Q8ND56 | S374 | Sugiyama | LSM14A C19orf13 FAM61A RAP55 RAP55A | EDPLGPNCYYDKTKsFFDNIsCDDNRERRPtWAEERRLNAE |
| Q8NE71 | S595 | Sugiyama | ABCF1 ABC50 | TKEALTRKQQKCRRKNQDEEsQEAPELLKRPKEYTVRFTFP |
| Q8TAM6 | S280 | Sugiyama | ERMN KIAA1189 | TISYRKIRKGNTKQRIDEFEsMMHL________________ |
| Q8TF05 | S547 | Sugiyama | PPP4R1 MEG1 PP4R1 | VEVLSAALRAssLDAHEEtIsIEKRSDLQDELDINELPNCK |
| Q8WVV9 | T46 | Sugiyama | HNRNPLL HNRPLL SRRF BLOCK24 | KTEEGEIDysAEEGENRREAtPRGGGDGGGGGRsFsQPEAG |
| Q92598 | S852 | Sugiyama | HSPH1 HSP105 HSP110 KIAA0201 | NNFGAEPPHQNGECyPNEKNsVNMDLD______________ |
| Q92785 | S142 | Sugiyama | DPF2 BAF45D REQ UBID4 | LLRTDPLEKRGAPDPRVDDDsLGEFPVTNsRARKRILEPDD |
| Q93062 | S14 | Sugiyama | RBPMS HERMES | _______MNNGGKAEKENtPsEANLQEEEVRTLFVSGLPLD |
| Q96CT7 | S122 | Sugiyama | CCDC124 | DtLRRDHQLREAPDTAEKAKsHLEVPLEENVNRRVLEEGsV |
| Q96E11 | S227 | Sugiyama | MRRF | SLRKVRTNSMNKLKKSKDTVsEDtIRLIEKQIsQMADDtVA |
| Q96E11 | T230 | Sugiyama | MRRF | KVRTNSMNKLKKSKDTVsEDtIRLIEKQIsQMADDtVAELD |
| Q96GM8 | S374 | Sugiyama | TOE1 | GTQtsGEAKDGPPKKQVCGDsIKPEETEQEVAADETRNLPH |
| Q96K76 | S865 | Sugiyama | USP47 | AGGDSGNVDDDCERVKGPVGsLKsVEAILEEstEKLKSLSL |
| Q96K76 | S868 | Sugiyama | USP47 | DSGNVDDDCERVKGPVGsLKsVEAILEEstEKLKSLSLQQQ |
| Q96KB5 | S298 | Sugiyama | PBK TOPK | RPPINMEELDESYQKVIELFsVCtNEDPKDRPsAAHIVEAL |
| Q96KB5 | T301 | Sugiyama | PBK TOPK | INMEELDESYQKVIELFsVCtNEDPKDRPsAAHIVEALEtD |
| Q96SB4 | S334 | Sugiyama | SRPK1 | ERPLKENPPNKMtQEKLEEsstIGQDQtLMERDTEGGAAEI |
| Q99614 | S90 | Sugiyama | TTC1 TPR1 | FEEEPGADKVENKsNEDVNssELDEEyLIELEKNMSDEEKQ |
| Q99733 | S121 | Sugiyama | NAP1L4 NAP2 | PLFDKRREFItGDVEPtDAEsEWHsENEEEEKLAGDMKSKV |
| Q99733 | S125 | Sugiyama | NAP1L4 NAP2 | KRREFItGDVEPtDAEsEWHsENEEEEKLAGDMKSKVVVTE |
| Q99848 | S269 | Sugiyama | EBNA1BP2 EBP2 | GFGGKKKGSKWNtREsyDDVssFRAKTAHGRGLKRPGKKGS |
| Q99848 | S270 | Sugiyama | EBNA1BP2 EBP2 | FGGKKKGSKWNtREsyDDVssFRAKTAHGRGLKRPGKKGSN |
| Q9BQE3 | T73 | Sugiyama | TUBA1C TUBA6 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q9BQE3 | Y83 | Sugiyama | TUBA1C TUBA6 | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| Q9BTC0 | S352 | Sugiyama | DIDO1 C20orf158 DATF1 KIAA0333 | TADQQEAKWRPGDADGTDCTsIGtIEQKSSEDQGIKGRIEK |
| Q9BTC0 | T355 | Sugiyama | DIDO1 C20orf158 DATF1 KIAA0333 | QQEAKWRPGDADGTDCTsIGtIEQKSSEDQGIKGRIEKAAN |
| Q9BVS4 | S332 | Sugiyama | RIOK2 RIO2 | DDELLHPLGPDDKNIETKEGsEFsFsDGEVAEKAEVyGsEN |
| Q9BVS4 | S335 | Sugiyama | RIOK2 RIO2 | LLHPLGPDDKNIETKEGsEFsFsDGEVAEKAEVyGsENEsE |
| Q9BVS4 | S412 | Sugiyama | RIOK2 RIO2 | EMTEFNQALEEIKGQVVENNsVTEFsEEKNRTENYNRQDGQ |
| Q9BWU0 | S709 | Sugiyama | SLC4A1AP HLC3 | SRGELKKKKTPGPGKLPPTLsSKYPEDDPDYCVWVPPEGQS |
| Q9BY32 | S53 | Sugiyama | ITPA C20orf37 My049 OK/SW-cl.9 | CTLVAQKIDLPEyQGEPDEIsIQKCQEAVRQVQGPVLVEDT |
| Q9BYX7 | S368 | Sugiyama | POTEKP ACTBL3 FKSG30 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q9C0C2 | S1174 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | ttAGsVDWTDQLGLRNLEVssCVGsGGssEAREsAVGQMGW |
| Q9H1E3 | S132 | Sugiyama | NUCKS1 NUCKS JC7 | GsEEEQEEEDEAPFQEKDsGsDEDFLMEDDDDsDyGSsKKK |
| Q9H2U2 | S309 | Sugiyama | PPA2 HSPC124 | NCTNVQISDSPFRCtQEEARsLVEsVsssPNKEsNEEEQVW |
| Q9H2U2 | S313 | Sugiyama | PPA2 HSPC124 | VQISDSPFRCtQEEARsLVEsVsssPNKEsNEEEQVWHFLG |
| Q9H6T3 | S507 | Sugiyama | RPAP3 | PTsDtPRAKVLKIEEVsDTssLQPQAsLKQDVCQsYsEKMP |
| Q9H8Y5 | S126 | Sugiyama | ANKZF1 ZNF744 | DKPLLSALDFEKQSSTGDLSsISGSEDSDSASEEDLQTLDR |
| Q9NQX3 | S262 | Sugiyama | GPHN GPH KIAA1385 | AKIPDSIISRGVQVLPRDTAsLsttPsEsPRAQAtsRLstA |
| Q9NR30 | S466 | Sugiyama | DDX21 | ETKKEAQELSQNsAIKQDAQsLHGDIPQKQREITLKGFRNG |
| Q9NW13 | S200 | Sugiyama | RBM28 | KGRTVAVDWAVAKDKYKDTQsVsAIGEEKSHESKHQESVKK |
| Q9NX58 | S32 | Sugiyama | LYAR PNAS-5 | sVKKIQVEKHVSVCRNCECLsCIDCGKDFWGDDYKNHVKCI |
| Q9NYL9 | S25 | Sugiyama | TMOD3 | FRKDLEKyKDLDEDELLGNLsEtELKQLETVLDDLDPENAL |
| Q9NZB2 | S417 | Sugiyama | FAM120A C9orf10 KIAA0183 OSSA | LSEPAPLTLDTSGKNLtEQNsysNIPHEGKHtPLyERssPI |
| Q9NZL9 | S110 | Sugiyama | MAT2B TGR MSTP045 Nbla02999 UNQ2435/PRO4995 | IVHCAAERRPDVVENQPDAAsQLNVDASGNLAKEAAAVGAF |
| Q9P2E9 | S1122 | Sugiyama | RRBP1 KIAA1398 | APAEPSSDLASKLREAEEtQstLQAECDQYRSILAETEGML |
| Q9P2E9 | T1120 | Sugiyama | RRBP1 KIAA1398 | PPAPAEPSSDLASKLREAEEtQstLQAECDQYRSILAETEG |
| Q9UPN9 | S787 | Sugiyama | TRIM33 KIAA1113 RFG7 TIF1G | SFKSDQVKVKQEPGTEDEICsFsGGVKQEKTEDGRRsACML |
| Q9UPQ9 | S992 | Sugiyama | TNRC6B KIAA1093 | TTGWGNTPANAPNAMKPNSKsMQDGWGESDGPVTGARHPsW |
| Q9UQ80 | S40 | Sugiyama | PA2G4 EBP1 | KYKMGGDIANRVLRsLVEASssGVsVLsLCEKGDAMIMEEt |
| Q9UQ80 | S44 | Sugiyama | PA2G4 EBP1 | GGDIANRVLRsLVEASssGVsVLsLCEKGDAMIMEEtGKIF |
| Q9UQ80 | S47 | Sugiyama | PA2G4 EBP1 | IANRVLRsLVEASssGVsVLsLCEKGDAMIMEEtGKIFKKE |
| Q9Y266 | S285 | Sugiyama | NUDC | NtKKINPENsKLsDLDsEtRsMVEKMMYDQRQKsMGLPtsD |
| Q9Y2B0 | S63 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | AQVDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLE |
| Q9Y383 | S347 | Sugiyama | LUC7L2 CGI-59 CGI-74 | SRERSKRRSSKERFRDQDLAsCDRDRssRDRSPRDRDRKDK |
| Q9Y3Z3 | S603 | Sugiyama | SAMHD1 MOP5 | DGDVIAPLItPQKKEWNDstsVQNPtRLREASKSRVQLFKD |
| Q9Y5M8 | S257 | Sugiyama | SRPRB PSEC0230 | LPLKVEFLECSAKGGRGDVGsADIQDLEKWLAKIA______ |
| Q9Y5P4 | S132 | SIGNOR|EPSD|PSP | CERT1 CERT COL4A3BP STARD11 | IEQHKTESGYGsEssLRRHGsMVsLVSGAsGYsAtstssFK |
| Q9Y5S9 | S56 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | KGRGFGsEEGsRARMREDyDsVEQDGDEPGPQRSVEGWILF |
| Q9Y696 | S31 | Sugiyama | CLIC4 | KEEDKEPLIELFVKAGsDGEsIGNCPFSQRLFMILWLKGVV |
| Q9Y6A5 | S583 | Sugiyama | TACC3 ERIC1 | FDPLLRDsPGRPVPVATEtssMHGANEtPSGRPREAKLVEF |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Signal Transduction | R-HSA-162582 | 3.514269e-10 | 9.454 | 1 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.739215e-08 | 7.760 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 2.640877e-08 | 7.578 | 0 | 0 |
| M Phase | R-HSA-68886 | 7.330511e-08 | 7.135 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 8.034833e-08 | 7.095 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 7.633932e-08 | 7.117 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 2.641690e-07 | 6.578 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 3.311109e-07 | 6.480 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 3.722925e-07 | 6.429 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 8.597261e-07 | 6.066 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 8.180595e-07 | 6.087 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 2.448550e-06 | 5.611 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 2.815305e-06 | 5.550 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 2.815305e-06 | 5.550 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 3.871865e-06 | 5.412 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 6.008884e-06 | 5.221 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 6.543039e-06 | 5.184 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 7.492901e-06 | 5.125 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 9.608253e-06 | 5.017 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.018324e-05 | 4.992 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.038608e-05 | 4.984 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.268088e-05 | 4.897 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.441631e-05 | 4.841 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.503901e-05 | 4.823 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.715978e-05 | 4.765 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.742731e-05 | 4.759 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.911920e-05 | 4.719 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 2.812414e-05 | 4.551 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 2.845345e-05 | 4.546 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 2.997376e-05 | 4.523 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 3.126293e-05 | 4.505 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 4.505516e-05 | 4.346 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 5.564024e-05 | 4.255 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 6.901284e-05 | 4.161 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 7.295120e-05 | 4.137 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 7.405384e-05 | 4.130 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 7.636826e-05 | 4.117 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 8.223480e-05 | 4.085 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 8.011631e-05 | 4.096 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 9.154262e-05 | 4.038 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 1.036344e-04 | 3.984 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.196027e-04 | 3.922 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.297086e-04 | 3.887 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.326682e-04 | 3.877 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.612797e-04 | 3.792 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.612797e-04 | 3.792 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.612797e-04 | 3.792 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 1.653597e-04 | 3.782 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 1.653597e-04 | 3.782 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.693140e-04 | 3.771 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.698311e-04 | 3.770 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.848197e-04 | 3.733 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.936833e-04 | 3.713 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 2.013405e-04 | 3.696 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 2.172849e-04 | 3.663 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 2.172849e-04 | 3.663 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.099244e-04 | 3.678 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 2.246287e-04 | 3.649 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 2.246287e-04 | 3.649 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 2.365104e-04 | 3.626 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 2.366738e-04 | 3.626 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 2.656882e-04 | 3.576 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 2.810331e-04 | 3.551 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 3.121362e-04 | 3.506 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 3.121362e-04 | 3.506 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 3.466599e-04 | 3.460 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 3.466599e-04 | 3.460 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 3.352165e-04 | 3.475 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 4.326601e-04 | 3.364 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 4.326601e-04 | 3.364 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 4.438054e-04 | 3.353 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 5.063800e-04 | 3.296 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 5.404477e-04 | 3.267 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 5.654118e-04 | 3.248 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 5.359918e-04 | 3.271 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 5.359918e-04 | 3.271 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 6.425343e-04 | 3.192 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 6.593182e-04 | 3.181 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 6.680984e-04 | 3.175 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 6.962760e-04 | 3.157 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 7.984467e-04 | 3.098 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 9.123133e-04 | 3.040 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 9.131960e-04 | 3.039 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 9.433211e-04 | 3.025 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 9.548241e-04 | 3.020 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 9.797771e-04 | 3.009 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.065884e-03 | 2.972 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 1.065324e-03 | 2.973 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 1.123830e-03 | 2.949 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.132930e-03 | 2.946 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 1.201913e-03 | 2.920 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.300406e-03 | 2.886 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.321946e-03 | 2.879 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 1.323206e-03 | 2.878 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 1.345597e-03 | 2.871 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 1.438817e-03 | 2.842 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 1.489357e-03 | 2.827 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 1.489357e-03 | 2.827 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.563458e-03 | 2.806 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.571914e-03 | 2.804 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.677672e-03 | 2.775 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 2.003032e-03 | 2.698 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.846193e-03 | 2.734 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.846193e-03 | 2.734 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.846193e-03 | 2.734 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.751294e-03 | 2.757 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.940441e-03 | 2.712 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.846193e-03 | 2.734 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 2.003714e-03 | 2.698 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 2.003032e-03 | 2.698 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.975778e-03 | 2.704 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 2.003714e-03 | 2.698 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.804340e-03 | 2.744 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.846193e-03 | 2.734 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.721709e-03 | 2.764 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 2.003032e-03 | 2.698 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 2.005555e-03 | 2.698 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 2.086696e-03 | 2.681 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 2.130029e-03 | 2.672 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 2.130029e-03 | 2.672 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 2.150137e-03 | 2.668 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 2.261692e-03 | 2.646 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 2.364254e-03 | 2.626 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 2.402315e-03 | 2.619 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 2.538423e-03 | 2.595 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 2.663588e-03 | 2.575 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 2.742563e-03 | 2.562 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 2.611781e-03 | 2.583 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 2.776891e-03 | 2.556 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 2.776891e-03 | 2.556 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 2.900599e-03 | 2.538 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 2.975182e-03 | 2.526 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 3.019196e-03 | 2.520 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 3.019196e-03 | 2.520 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 3.196193e-03 | 2.495 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 3.280481e-03 | 2.484 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 3.299608e-03 | 2.482 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 3.299608e-03 | 2.482 | 0 | 0 |
| Depurination | R-HSA-73927 | 3.565314e-03 | 2.448 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 3.719180e-03 | 2.430 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 3.777495e-03 | 2.423 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 3.804189e-03 | 2.420 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 4.115064e-03 | 2.386 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 4.442025e-03 | 2.352 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 4.615384e-03 | 2.336 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 4.805041e-03 | 2.318 | 1 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 4.963322e-03 | 2.304 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 5.051817e-03 | 2.297 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 5.457137e-03 | 2.263 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 5.468744e-03 | 2.262 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 5.654841e-03 | 2.248 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 6.004640e-03 | 2.222 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 6.372233e-03 | 2.196 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 6.842523e-03 | 2.165 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 6.473870e-03 | 2.189 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 6.869303e-03 | 2.163 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 6.536197e-03 | 2.185 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 6.536197e-03 | 2.185 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 6.779971e-03 | 2.169 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 7.160587e-03 | 2.145 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 7.160587e-03 | 2.145 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 6.996839e-03 | 2.155 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 7.209468e-03 | 2.142 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 6.570014e-03 | 2.182 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 7.561716e-03 | 2.121 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 8.189946e-03 | 2.087 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 8.365222e-03 | 2.078 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 8.367515e-03 | 2.077 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 8.597860e-03 | 2.066 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 8.820075e-03 | 2.055 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 8.857614e-03 | 2.053 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 8.857614e-03 | 2.053 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 8.857614e-03 | 2.053 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 8.971925e-03 | 2.047 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 8.971925e-03 | 2.047 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 8.971925e-03 | 2.047 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 9.930228e-03 | 2.003 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.017361e-02 | 1.993 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 1.146885e-02 | 1.940 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.123118e-02 | 1.950 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 1.071635e-02 | 1.970 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 1.123118e-02 | 1.950 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 1.188428e-02 | 1.925 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.177876e-02 | 1.929 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.055085e-02 | 1.977 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.072714e-02 | 1.970 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 1.152388e-02 | 1.938 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 1.250794e-02 | 1.903 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 1.270634e-02 | 1.896 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 1.283212e-02 | 1.892 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 1.299195e-02 | 1.886 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 1.300794e-02 | 1.886 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 1.303596e-02 | 1.885 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 1.334214e-02 | 1.875 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 1.355449e-02 | 1.868 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 1.355449e-02 | 1.868 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.355449e-02 | 1.868 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 1.355449e-02 | 1.868 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 1.386716e-02 | 1.858 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.431050e-02 | 1.844 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.435715e-02 | 1.843 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 1.449314e-02 | 1.839 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 1.535309e-02 | 1.814 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 1.535309e-02 | 1.814 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.694498e-02 | 1.771 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.712334e-02 | 1.766 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.724350e-02 | 1.763 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.784561e-02 | 1.748 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 1.853466e-02 | 1.732 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 1.853466e-02 | 1.732 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.958421e-02 | 1.708 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 1.958421e-02 | 1.708 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 1.958421e-02 | 1.708 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.088557e-02 | 1.680 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 1.984977e-02 | 1.702 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 2.003509e-02 | 1.698 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 1.984977e-02 | 1.702 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.851459e-02 | 1.732 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.970693e-02 | 1.705 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 1.958421e-02 | 1.708 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 2.151672e-02 | 1.667 | 1 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 2.244878e-02 | 1.649 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 2.252405e-02 | 1.647 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 2.352002e-02 | 1.629 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 2.531930e-02 | 1.597 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 2.584881e-02 | 1.588 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 2.584881e-02 | 1.588 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 2.593609e-02 | 1.586 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 2.665696e-02 | 1.574 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 2.665696e-02 | 1.574 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 2.710833e-02 | 1.567 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 2.809533e-02 | 1.551 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 2.842491e-02 | 1.546 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 2.864139e-02 | 1.543 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 2.960434e-02 | 1.529 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.965706e-02 | 1.528 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 2.985828e-02 | 1.525 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 2.985828e-02 | 1.525 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 2.985828e-02 | 1.525 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 2.985828e-02 | 1.525 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 2.991064e-02 | 1.524 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 3.001016e-02 | 1.523 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 3.026685e-02 | 1.519 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 3.164403e-02 | 1.500 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 3.247867e-02 | 1.488 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 3.493348e-02 | 1.457 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 3.384912e-02 | 1.470 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 3.818712e-02 | 1.418 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 3.214833e-02 | 1.493 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 3.569749e-02 | 1.447 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 3.846711e-02 | 1.415 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 3.846711e-02 | 1.415 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 3.739963e-02 | 1.427 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 3.401114e-02 | 1.468 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 3.385521e-02 | 1.470 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 3.846711e-02 | 1.415 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 3.826932e-02 | 1.417 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 3.206516e-02 | 1.494 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 3.594221e-02 | 1.444 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 3.318825e-02 | 1.479 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 3.918992e-02 | 1.407 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 3.954544e-02 | 1.403 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 4.003197e-02 | 1.398 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 4.532693e-02 | 1.344 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 4.566967e-02 | 1.340 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 4.634202e-02 | 1.334 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 4.634202e-02 | 1.334 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 5.115863e-02 | 1.291 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 5.119405e-02 | 1.291 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 5.119405e-02 | 1.291 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 5.119405e-02 | 1.291 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 5.125187e-02 | 1.290 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 5.127656e-02 | 1.290 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 5.300713e-02 | 1.276 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 5.300713e-02 | 1.276 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 5.300713e-02 | 1.276 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 5.300713e-02 | 1.276 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 5.300713e-02 | 1.276 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 5.300713e-02 | 1.276 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 5.300713e-02 | 1.276 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 5.300713e-02 | 1.276 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 5.300713e-02 | 1.276 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 5.300713e-02 | 1.276 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 5.300713e-02 | 1.276 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 5.300713e-02 | 1.276 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 5.380708e-02 | 1.269 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 5.399833e-02 | 1.268 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 5.407166e-02 | 1.267 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 5.440776e-02 | 1.264 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 5.440776e-02 | 1.264 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 6.587453e-02 | 1.181 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 6.587453e-02 | 1.181 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 6.323447e-02 | 1.199 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 6.323447e-02 | 1.199 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 6.911849e-02 | 1.160 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 5.891851e-02 | 1.230 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 5.623421e-02 | 1.250 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 5.949765e-02 | 1.226 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 6.430493e-02 | 1.192 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 5.891851e-02 | 1.230 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 6.758801e-02 | 1.170 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 5.751839e-02 | 1.240 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 6.911849e-02 | 1.160 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 5.996850e-02 | 1.222 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 5.705930e-02 | 1.244 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 6.731065e-02 | 1.172 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 6.254970e-02 | 1.204 | 0 | 0 |
| S Phase | R-HSA-69242 | 5.985748e-02 | 1.223 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 5.780848e-02 | 1.238 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 6.340853e-02 | 1.198 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 6.539061e-02 | 1.184 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 6.516932e-02 | 1.186 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 5.985748e-02 | 1.223 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 6.911849e-02 | 1.160 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 6.443712e-02 | 1.191 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 5.667935e-02 | 1.247 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 6.988230e-02 | 1.156 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 7.015001e-02 | 1.154 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 7.015001e-02 | 1.154 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 7.155639e-02 | 1.145 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 7.155639e-02 | 1.145 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 7.155639e-02 | 1.145 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 7.415923e-02 | 1.130 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 7.474017e-02 | 1.126 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 7.618755e-02 | 1.118 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 7.750464e-02 | 1.111 | 0 | 0 |
| Signaling by FGFR1 amplification mutants | R-HSA-1839120 | 7.807836e-02 | 1.107 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 7.807836e-02 | 1.107 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 7.807836e-02 | 1.107 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 8.044807e-02 | 1.094 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 8.056621e-02 | 1.094 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 8.214445e-02 | 1.085 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 8.214445e-02 | 1.085 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 8.314765e-02 | 1.080 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 8.314765e-02 | 1.080 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 8.417138e-02 | 1.075 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 8.423702e-02 | 1.074 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 8.775720e-02 | 1.057 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 8.775720e-02 | 1.057 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 8.775720e-02 | 1.057 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 8.775720e-02 | 1.057 | 0 | 0 |
| Deletions in the AMER1 gene destabilize the destruction complex | R-HSA-5467343 | 8.775720e-02 | 1.057 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 8.775720e-02 | 1.057 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 8.775720e-02 | 1.057 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 8.775720e-02 | 1.057 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 1.060433e-01 | 0.975 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 1.060433e-01 | 0.975 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 9.995053e-02 | 1.000 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 9.995053e-02 | 1.000 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 9.995053e-02 | 1.000 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 1.145945e-01 | 0.941 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.145945e-01 | 0.941 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 1.059776e-01 | 0.975 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 9.658210e-02 | 1.015 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 9.658210e-02 | 1.015 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 1.068578e-01 | 0.971 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 8.745392e-02 | 1.058 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 9.405987e-02 | 1.027 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.061636e-01 | 0.974 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.086426e-01 | 0.964 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 1.045274e-01 | 0.981 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 1.009739e-01 | 0.996 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 1.009739e-01 | 0.996 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 1.009739e-01 | 0.996 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 1.145945e-01 | 0.941 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 9.609446e-02 | 1.017 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.060433e-01 | 0.975 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 1.060433e-01 | 0.975 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 1.019430e-01 | 0.992 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 9.993317e-02 | 1.000 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 8.727617e-02 | 1.059 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 1.068578e-01 | 0.971 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 9.995053e-02 | 1.000 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 1.068578e-01 | 0.971 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 1.068578e-01 | 0.971 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.036711e-01 | 0.984 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 1.086426e-01 | 0.964 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 9.029960e-02 | 1.044 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 9.995053e-02 | 1.000 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 1.021927e-01 | 0.991 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 8.621120e-02 | 1.064 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 9.220900e-02 | 1.035 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 1.039101e-01 | 0.983 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 1.107051e-01 | 0.956 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 1.011089e-01 | 0.995 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 8.631101e-02 | 1.064 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 9.993317e-02 | 1.000 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 8.612102e-02 | 1.065 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 9.572205e-02 | 1.019 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.011089e-01 | 0.995 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.173741e-01 | 0.930 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 1.176733e-01 | 0.929 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.191443e-01 | 0.924 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.191443e-01 | 0.924 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 1.191443e-01 | 0.924 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.191443e-01 | 0.924 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.239584e-01 | 0.907 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.239584e-01 | 0.907 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 1.244869e-01 | 0.905 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 1.273221e-01 | 0.895 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.289922e-01 | 0.889 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 1.301362e-01 | 0.886 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.301362e-01 | 0.886 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 1.356133e-01 | 0.868 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 1.356133e-01 | 0.868 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 1.356133e-01 | 0.868 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.362016e-01 | 0.866 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 1.362016e-01 | 0.866 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.362016e-01 | 0.866 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 1.362016e-01 | 0.866 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 1.362016e-01 | 0.866 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 1.376085e-01 | 0.861 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.384548e-01 | 0.859 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.395698e-01 | 0.855 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 1.395698e-01 | 0.855 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 1.395698e-01 | 0.855 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 1.399235e-01 | 0.854 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 1.400218e-01 | 0.854 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 1.452658e-01 | 0.838 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 1.452658e-01 | 0.838 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 1.452658e-01 | 0.838 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 1.459196e-01 | 0.836 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 1.464776e-01 | 0.834 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 1.464938e-01 | 0.834 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.678178e-01 | 0.775 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.678178e-01 | 0.775 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.678178e-01 | 0.775 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.678178e-01 | 0.775 | 0 | 0 |
| Drug-mediated inhibition of MET activation | R-HSA-9734091 | 1.678178e-01 | 0.775 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.678178e-01 | 0.775 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.678178e-01 | 0.775 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 2.408565e-01 | 0.618 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.408565e-01 | 0.618 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 2.408565e-01 | 0.618 | 0 | 0 |
| Defective SLC34A2 causes PALM | R-HSA-5687583 | 2.408565e-01 | 0.618 | 0 | 0 |
| Defective SLC34A2 causes pulmonary alveolar microlithiasis (PALM) | R-HSA-5619045 | 2.408565e-01 | 0.618 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 1.679537e-01 | 0.775 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 1.679537e-01 | 0.775 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 1.679537e-01 | 0.775 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 3.074886e-01 | 0.512 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 3.074886e-01 | 0.512 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 3.074886e-01 | 0.512 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 3.074886e-01 | 0.512 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 3.074886e-01 | 0.512 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 2.007880e-01 | 0.697 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 2.007880e-01 | 0.697 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 2.007880e-01 | 0.697 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 1.610683e-01 | 0.793 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.610683e-01 | 0.793 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 1.610683e-01 | 0.793 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 2.342704e-01 | 0.630 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.342704e-01 | 0.630 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 2.342704e-01 | 0.630 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 2.342704e-01 | 0.630 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 2.342704e-01 | 0.630 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 2.342704e-01 | 0.630 | 0 | 0 |
| Activated NTRK3 signals through PLCG1 | R-HSA-9034793 | 3.682759e-01 | 0.434 | 0 | 0 |
| PLC-gamma1 signalling | R-HSA-167021 | 3.682759e-01 | 0.434 | 0 | 0 |
| Signaling by plasma membrane FGFR1 fusions | R-HSA-8853336 | 3.682759e-01 | 0.434 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 3.682759e-01 | 0.434 | 0 | 0 |
| Signalling to STAT3 | R-HSA-198745 | 3.682759e-01 | 0.434 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 3.682759e-01 | 0.434 | 0 | 0 |
| Adrenaline signalling through Alpha-2 adrenergic receptor | R-HSA-392023 | 3.682759e-01 | 0.434 | 0 | 0 |
| Defective SLC7A7 causes lysinuric protein intolerance (LPI) | R-HSA-5660862 | 3.682759e-01 | 0.434 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.834812e-01 | 0.736 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.834812e-01 | 0.736 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 2.680347e-01 | 0.572 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 2.680347e-01 | 0.572 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 2.680347e-01 | 0.572 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 2.680347e-01 | 0.572 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 2.066533e-01 | 0.685 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 2.066533e-01 | 0.685 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 2.066533e-01 | 0.685 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.635986e-01 | 0.786 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 1.813788e-01 | 0.741 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 3.017736e-01 | 0.520 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 3.017736e-01 | 0.520 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 3.017736e-01 | 0.520 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 3.017736e-01 | 0.520 | 0 | 0 |
| Activated NTRK2 signals through PLCG1 | R-HSA-9026527 | 4.237307e-01 | 0.373 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 4.237307e-01 | 0.373 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 4.237307e-01 | 0.373 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 4.237307e-01 | 0.373 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 4.237307e-01 | 0.373 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 4.237307e-01 | 0.373 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 1.595770e-01 | 0.797 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.997608e-01 | 0.699 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.997608e-01 | 0.699 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 2.546812e-01 | 0.594 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 2.546812e-01 | 0.594 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 2.546812e-01 | 0.594 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 1.744325e-01 | 0.758 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 3.352318e-01 | 0.475 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 3.352318e-01 | 0.475 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 3.352318e-01 | 0.475 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 2.056091e-01 | 0.687 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 3.040397e-01 | 0.517 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 3.681988e-01 | 0.434 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 3.681988e-01 | 0.434 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 3.681988e-01 | 0.434 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 3.681988e-01 | 0.434 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 3.289077e-01 | 0.483 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.802683e-01 | 0.744 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 2.358041e-01 | 0.627 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 4.005032e-01 | 0.397 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 4.005032e-01 | 0.397 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 4.005032e-01 | 0.397 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 4.005032e-01 | 0.397 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 4.005032e-01 | 0.397 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 4.005032e-01 | 0.397 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 2.659627e-01 | 0.575 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 2.659627e-01 | 0.575 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 3.784825e-01 | 0.422 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 4.320074e-01 | 0.365 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 4.320074e-01 | 0.365 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 4.320074e-01 | 0.365 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 4.320074e-01 | 0.365 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 4.320074e-01 | 0.365 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 4.320074e-01 | 0.365 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 4.320074e-01 | 0.365 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 4.320074e-01 | 0.365 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 4.320074e-01 | 0.365 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 4.320074e-01 | 0.365 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 4.320074e-01 | 0.365 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 4.320074e-01 | 0.365 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 2.162708e-01 | 0.665 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 2.267637e-01 | 0.644 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 2.055015e-01 | 0.687 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 2.643104e-01 | 0.578 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 3.597035e-01 | 0.444 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 3.597035e-01 | 0.444 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 3.597035e-01 | 0.444 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 2.868474e-01 | 0.542 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 2.374478e-01 | 0.624 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 4.030026e-01 | 0.395 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 4.030026e-01 | 0.395 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 4.030026e-01 | 0.395 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 4.030026e-01 | 0.395 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 4.272356e-01 | 0.369 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 4.007849e-01 | 0.397 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 2.828995e-01 | 0.548 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.828557e-01 | 0.738 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 3.769558e-01 | 0.424 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 4.211652e-01 | 0.376 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 3.740958e-01 | 0.427 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 2.512074e-01 | 0.600 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 2.680316e-01 | 0.572 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 4.068423e-01 | 0.391 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 4.272356e-01 | 0.369 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 4.272356e-01 | 0.369 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 4.257672e-01 | 0.371 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 3.289077e-01 | 0.483 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 3.289077e-01 | 0.483 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 2.553758e-01 | 0.593 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 2.090513e-01 | 0.680 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 1.587108e-01 | 0.799 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 2.725842e-01 | 0.564 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 2.705366e-01 | 0.568 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 4.328913e-01 | 0.364 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 4.030026e-01 | 0.395 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 3.352318e-01 | 0.475 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 3.391086e-01 | 0.470 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 3.352318e-01 | 0.475 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 1.917237e-01 | 0.717 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 3.034232e-01 | 0.518 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 1.635986e-01 | 0.786 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 3.040397e-01 | 0.517 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 2.342704e-01 | 0.630 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 2.342704e-01 | 0.630 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 3.017736e-01 | 0.520 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 3.352318e-01 | 0.475 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 2.380320e-01 | 0.623 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 3.681988e-01 | 0.434 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 3.681988e-01 | 0.434 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 4.005032e-01 | 0.397 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 2.725842e-01 | 0.564 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 3.537546e-01 | 0.451 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 4.328913e-01 | 0.364 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 3.572903e-01 | 0.447 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 3.254374e-01 | 0.488 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 2.792584e-01 | 0.554 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 2.792584e-01 | 0.554 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 4.320074e-01 | 0.365 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 4.123102e-01 | 0.385 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 3.436943e-01 | 0.464 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.839124e-01 | 0.735 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 4.005032e-01 | 0.397 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 4.320074e-01 | 0.365 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 4.320074e-01 | 0.365 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 3.612629e-01 | 0.442 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 4.257672e-01 | 0.371 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 1.610683e-01 | 0.793 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 4.005032e-01 | 0.397 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 3.597035e-01 | 0.444 | 1 | 1 |
| Degradation of DVL | R-HSA-4641258 | 3.792293e-01 | 0.421 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 4.113313e-01 | 0.386 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 3.155137e-01 | 0.501 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 3.017736e-01 | 0.520 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 2.186700e-01 | 0.660 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 3.681988e-01 | 0.434 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 4.005032e-01 | 0.397 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 3.537546e-01 | 0.451 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 3.185546e-01 | 0.497 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 2.900268e-01 | 0.538 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 3.784825e-01 | 0.422 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 4.211652e-01 | 0.376 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 4.150788e-01 | 0.382 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 4.413363e-01 | 0.355 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 4.351507e-01 | 0.361 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.484140e-01 | 0.829 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 1.744325e-01 | 0.758 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 3.891999e-01 | 0.410 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.792584e-01 | 0.554 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 4.030026e-01 | 0.395 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 1.927950e-01 | 0.715 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 2.577729e-01 | 0.589 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 3.017736e-01 | 0.520 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 2.546812e-01 | 0.594 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 1.744325e-01 | 0.758 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 4.030026e-01 | 0.395 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 3.295544e-01 | 0.482 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 4.184199e-01 | 0.378 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 2.374015e-01 | 0.625 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 1.929593e-01 | 0.715 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 4.005784e-01 | 0.397 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 2.007880e-01 | 0.697 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 3.040397e-01 | 0.517 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 3.784825e-01 | 0.422 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 3.612629e-01 | 0.442 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.929593e-01 | 0.715 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 1.834812e-01 | 0.736 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 1.813788e-01 | 0.741 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 2.546812e-01 | 0.594 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 3.167426e-01 | 0.499 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 3.503750e-01 | 0.455 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 2.471257e-01 | 0.607 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 2.107581e-01 | 0.676 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 2.471257e-01 | 0.607 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 2.734794e-01 | 0.563 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 1.678178e-01 | 0.775 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 1.678178e-01 | 0.775 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 3.074886e-01 | 0.512 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 3.074886e-01 | 0.512 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 3.074886e-01 | 0.512 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 3.074886e-01 | 0.512 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 2.007880e-01 | 0.697 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.610683e-01 | 0.793 | 0 | 0 |
| Type II Na+/Pi cotransporters | R-HSA-427589 | 3.682759e-01 | 0.434 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 2.066533e-01 | 0.685 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 2.066533e-01 | 0.685 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 2.066533e-01 | 0.685 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 3.017736e-01 | 0.520 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 3.352318e-01 | 0.475 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 3.681988e-01 | 0.434 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 3.681988e-01 | 0.434 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.778201e-01 | 0.556 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 4.005032e-01 | 0.397 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 3.537546e-01 | 0.451 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 3.076591e-01 | 0.512 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 3.433191e-01 | 0.464 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 3.155137e-01 | 0.501 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 2.530748e-01 | 0.597 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 2.644517e-01 | 0.578 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 2.734794e-01 | 0.563 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 4.413738e-01 | 0.355 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 2.891918e-01 | 0.539 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 4.150788e-01 | 0.382 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 1.543014e-01 | 0.812 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 4.150788e-01 | 0.382 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 3.642909e-01 | 0.439 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 1.595770e-01 | 0.797 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 2.451515e-01 | 0.611 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.511624e-01 | 0.821 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 3.467415e-01 | 0.460 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 2.030202e-01 | 0.692 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 2.186700e-01 | 0.660 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 3.352318e-01 | 0.475 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 3.810114e-01 | 0.419 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 4.230051e-01 | 0.374 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.751616e-01 | 0.757 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 2.615580e-01 | 0.582 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 2.306405e-01 | 0.637 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 4.413738e-01 | 0.355 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 4.320074e-01 | 0.365 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 3.076591e-01 | 0.512 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 1.679537e-01 | 0.775 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 2.304343e-01 | 0.637 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 3.017736e-01 | 0.520 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 4.237307e-01 | 0.373 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 2.546812e-01 | 0.594 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 1.860438e-01 | 0.730 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 4.320074e-01 | 0.365 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 2.407875e-01 | 0.618 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 2.200188e-01 | 0.658 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 2.391958e-01 | 0.621 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 2.744447e-01 | 0.562 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 4.320074e-01 | 0.365 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 4.211652e-01 | 0.376 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 2.117992e-01 | 0.674 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 4.236655e-01 | 0.373 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 3.792293e-01 | 0.421 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 2.184943e-01 | 0.661 | 0 | 0 |
| Inhibition of membrane repair | R-HSA-9635644 | 2.408565e-01 | 0.618 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 2.007880e-01 | 0.697 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 4.237307e-01 | 0.373 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 3.352318e-01 | 0.475 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 3.681988e-01 | 0.434 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 2.067933e-01 | 0.684 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 4.005032e-01 | 0.397 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 2.900268e-01 | 0.538 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 4.320074e-01 | 0.365 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 4.253139e-01 | 0.371 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 2.374015e-01 | 0.625 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 4.394438e-01 | 0.357 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 2.374015e-01 | 0.625 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 2.286416e-01 | 0.641 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 1.950267e-01 | 0.710 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 3.128050e-01 | 0.505 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 1.691558e-01 | 0.772 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 2.049124e-01 | 0.688 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 3.960769e-01 | 0.402 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 2.342704e-01 | 0.630 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 2.680347e-01 | 0.572 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 2.644457e-01 | 0.578 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 1.997608e-01 | 0.699 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 3.740958e-01 | 0.427 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 4.237307e-01 | 0.373 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 2.507555e-01 | 0.601 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 3.537546e-01 | 0.451 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 3.612629e-01 | 0.442 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 4.121538e-01 | 0.385 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.637925e-01 | 0.786 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 4.013128e-01 | 0.397 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 2.778201e-01 | 0.556 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 2.900268e-01 | 0.538 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 3.017736e-01 | 0.520 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 2.577729e-01 | 0.589 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 2.516153e-01 | 0.599 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 3.681988e-01 | 0.434 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.947835e-01 | 0.710 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 2.304343e-01 | 0.637 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 4.272356e-01 | 0.369 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 3.971800e-01 | 0.401 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 4.257672e-01 | 0.371 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 3.044192e-01 | 0.517 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 2.146910e-01 | 0.668 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 3.971800e-01 | 0.401 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 1.635986e-01 | 0.786 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 2.981034e-01 | 0.526 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 2.981034e-01 | 0.526 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 3.447391e-01 | 0.463 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 3.352318e-01 | 0.475 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 2.792584e-01 | 0.554 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 3.597035e-01 | 0.444 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 3.681988e-01 | 0.434 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 2.266548e-01 | 0.645 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 3.740958e-01 | 0.427 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 3.016443e-01 | 0.521 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 4.272356e-01 | 0.369 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 3.572903e-01 | 0.447 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 4.276924e-01 | 0.369 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 4.487726e-01 | 0.348 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 4.505850e-01 | 0.346 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 4.505850e-01 | 0.346 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 4.511111e-01 | 0.346 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 4.511111e-01 | 0.346 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 4.511111e-01 | 0.346 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 4.511111e-01 | 0.346 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 4.511111e-01 | 0.346 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 4.529152e-01 | 0.344 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 4.530769e-01 | 0.344 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 4.552235e-01 | 0.342 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 4.572694e-01 | 0.340 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 4.572715e-01 | 0.340 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 4.574358e-01 | 0.340 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 4.624512e-01 | 0.335 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 4.626031e-01 | 0.335 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 4.626031e-01 | 0.335 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 4.626031e-01 | 0.335 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 4.626031e-01 | 0.335 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 4.626031e-01 | 0.335 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 4.681295e-01 | 0.330 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 4.681295e-01 | 0.330 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 4.681295e-01 | 0.330 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 4.741884e-01 | 0.324 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 4.741884e-01 | 0.324 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 4.741884e-01 | 0.324 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 4.743204e-01 | 0.324 | 0 | 0 |
| FGFR1c and Klotho ligand binding and activation | R-HSA-190374 | 4.743204e-01 | 0.324 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 4.743204e-01 | 0.324 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 4.743204e-01 | 0.324 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 4.743204e-01 | 0.324 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 4.743204e-01 | 0.324 | 0 | 0 |
| PTK6 Activates STAT3 | R-HSA-8849474 | 4.743204e-01 | 0.324 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 4.743204e-01 | 0.324 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 4.743204e-01 | 0.324 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 4.743204e-01 | 0.324 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 4.743204e-01 | 0.324 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 4.743204e-01 | 0.324 | 0 | 0 |
| Inositol transporters | R-HSA-429593 | 4.743204e-01 | 0.324 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 4.743204e-01 | 0.324 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 4.743204e-01 | 0.324 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 4.743204e-01 | 0.324 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 4.745672e-01 | 0.324 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 4.745672e-01 | 0.324 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 4.745672e-01 | 0.324 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 4.745672e-01 | 0.324 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 4.838977e-01 | 0.315 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 4.906787e-01 | 0.309 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 4.921870e-01 | 0.308 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 4.922070e-01 | 0.308 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 4.922070e-01 | 0.308 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 4.922070e-01 | 0.308 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 4.922070e-01 | 0.308 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 4.922070e-01 | 0.308 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 4.935680e-01 | 0.307 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 4.975504e-01 | 0.303 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 4.975504e-01 | 0.303 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 4.975504e-01 | 0.303 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 4.975504e-01 | 0.303 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 4.975504e-01 | 0.303 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 5.043114e-01 | 0.297 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 5.056887e-01 | 0.296 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 5.059738e-01 | 0.296 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 5.068828e-01 | 0.295 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 5.068828e-01 | 0.295 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 5.079458e-01 | 0.294 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 5.195941e-01 | 0.284 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 5.195941e-01 | 0.284 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 5.196729e-01 | 0.284 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 5.196729e-01 | 0.284 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 5.196729e-01 | 0.284 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 5.200851e-01 | 0.284 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 5.203631e-01 | 0.284 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 5.204718e-01 | 0.284 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 5.204718e-01 | 0.284 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 5.204718e-01 | 0.284 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 5.204718e-01 | 0.284 | 0 | 0 |
| Loss-of-function mutations in DBT cause MSUD2 | R-HSA-9865113 | 5.204718e-01 | 0.284 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 5.204718e-01 | 0.284 | 0 | 0 |
| Loss-of-function mutations in DLD cause MSUD3/DLDD | R-HSA-9907570 | 5.204718e-01 | 0.284 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 5.204718e-01 | 0.284 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 5.204718e-01 | 0.284 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 5.204718e-01 | 0.284 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 5.204718e-01 | 0.284 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 5.204718e-01 | 0.284 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 5.204718e-01 | 0.284 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 5.204718e-01 | 0.284 | 0 | 0 |
| Orexin and neuropeptides FF and QRFP bind to their respective receptors | R-HSA-389397 | 5.204718e-01 | 0.284 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 5.206682e-01 | 0.283 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 5.207575e-01 | 0.283 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 5.207575e-01 | 0.283 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 5.207575e-01 | 0.283 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 5.207575e-01 | 0.283 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 5.207575e-01 | 0.283 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 5.207575e-01 | 0.283 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 5.207575e-01 | 0.283 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 5.207575e-01 | 0.283 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 5.207575e-01 | 0.283 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 5.207575e-01 | 0.283 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 5.207575e-01 | 0.283 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 5.207575e-01 | 0.283 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 5.207575e-01 | 0.283 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 5.320007e-01 | 0.274 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 5.348431e-01 | 0.272 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 5.348431e-01 | 0.272 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 5.362782e-01 | 0.271 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 5.362782e-01 | 0.271 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 5.384415e-01 | 0.269 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 5.419209e-01 | 0.266 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 5.476982e-01 | 0.261 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 5.482114e-01 | 0.261 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 5.482114e-01 | 0.261 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 5.482114e-01 | 0.261 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 5.482114e-01 | 0.261 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 5.482114e-01 | 0.261 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 5.482114e-01 | 0.261 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 5.498073e-01 | 0.260 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 5.526917e-01 | 0.258 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 5.568311e-01 | 0.254 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 5.568311e-01 | 0.254 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 5.568311e-01 | 0.254 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 5.568311e-01 | 0.254 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 5.625738e-01 | 0.250 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 5.625738e-01 | 0.250 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 5.625738e-01 | 0.250 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 5.625738e-01 | 0.250 | 0 | 0 |
| H139Hfs13* PPM1K causes a mild variant of MSUD | R-HSA-9912529 | 5.625738e-01 | 0.250 | 0 | 0 |
| Loss-of-function mutations in BCKDHA or BCKDHB cause MSUD | R-HSA-9865125 | 5.625738e-01 | 0.250 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 5.625738e-01 | 0.250 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 5.625738e-01 | 0.250 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 5.625738e-01 | 0.250 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 5.625738e-01 | 0.250 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 5.632371e-01 | 0.249 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 5.632371e-01 | 0.249 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 5.632371e-01 | 0.249 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 5.632371e-01 | 0.249 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 5.632371e-01 | 0.249 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 5.632371e-01 | 0.249 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 5.645499e-01 | 0.248 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 5.655295e-01 | 0.248 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 5.688162e-01 | 0.245 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 5.745413e-01 | 0.241 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 5.745413e-01 | 0.241 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 5.745413e-01 | 0.241 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 5.745413e-01 | 0.241 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 5.745413e-01 | 0.241 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 5.745413e-01 | 0.241 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 5.748194e-01 | 0.240 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 5.791468e-01 | 0.237 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 5.806875e-01 | 0.236 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 5.823264e-01 | 0.235 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 5.838715e-01 | 0.234 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 5.839373e-01 | 0.234 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 5.839373e-01 | 0.234 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 5.839373e-01 | 0.234 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 5.839373e-01 | 0.234 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 5.853001e-01 | 0.233 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 5.875438e-01 | 0.231 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 5.915359e-01 | 0.228 | 0 | 0 |
| Kinesins | R-HSA-983189 | 5.933169e-01 | 0.227 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 5.965591e-01 | 0.224 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 5.976128e-01 | 0.224 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 5.997328e-01 | 0.222 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 5.997328e-01 | 0.222 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 5.997328e-01 | 0.222 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 5.997328e-01 | 0.222 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 6.001347e-01 | 0.222 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 6.001347e-01 | 0.222 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 6.009816e-01 | 0.221 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 6.009816e-01 | 0.221 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 6.009816e-01 | 0.221 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis | R-HSA-9632974 | 6.009816e-01 | 0.221 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 6.009816e-01 | 0.221 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 6.009816e-01 | 0.221 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 6.009816e-01 | 0.221 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 6.009816e-01 | 0.221 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 6.009816e-01 | 0.221 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 6.009816e-01 | 0.221 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 6.009816e-01 | 0.221 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 6.009816e-01 | 0.221 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 6.009816e-01 | 0.221 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 6.009816e-01 | 0.221 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 6.009816e-01 | 0.221 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 6.009816e-01 | 0.221 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 6.009816e-01 | 0.221 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 6.040010e-01 | 0.219 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 6.040010e-01 | 0.219 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 6.040010e-01 | 0.219 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 6.071245e-01 | 0.217 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 6.095179e-01 | 0.215 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 6.095179e-01 | 0.215 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 6.097118e-01 | 0.215 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 6.106782e-01 | 0.214 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 6.234131e-01 | 0.205 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 6.234131e-01 | 0.205 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 6.234131e-01 | 0.205 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 6.234131e-01 | 0.205 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 6.237828e-01 | 0.205 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 6.237828e-01 | 0.205 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 6.237828e-01 | 0.205 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 6.237828e-01 | 0.205 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 6.261985e-01 | 0.203 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 6.261985e-01 | 0.203 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 6.261985e-01 | 0.203 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 6.261985e-01 | 0.203 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 6.261985e-01 | 0.203 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 6.261985e-01 | 0.203 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 6.261985e-01 | 0.203 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 6.261985e-01 | 0.203 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 6.266549e-01 | 0.203 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 6.293799e-01 | 0.201 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 6.317380e-01 | 0.199 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 6.360191e-01 | 0.197 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 6.360191e-01 | 0.197 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 6.360191e-01 | 0.197 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 6.360191e-01 | 0.197 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 6.360191e-01 | 0.197 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 6.360191e-01 | 0.197 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 6.360191e-01 | 0.197 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 6.360191e-01 | 0.197 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 6.360191e-01 | 0.197 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 6.360191e-01 | 0.197 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 6.360191e-01 | 0.197 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 6.360191e-01 | 0.197 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 6.360191e-01 | 0.197 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 6.360191e-01 | 0.197 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 6.389262e-01 | 0.195 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 6.421630e-01 | 0.192 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 6.421630e-01 | 0.192 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 6.421630e-01 | 0.192 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 6.424181e-01 | 0.192 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 6.424181e-01 | 0.192 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 6.424181e-01 | 0.192 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 6.445965e-01 | 0.191 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 6.445965e-01 | 0.191 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 6.466976e-01 | 0.189 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 6.466976e-01 | 0.189 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 6.466976e-01 | 0.189 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 6.466976e-01 | 0.189 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 6.466976e-01 | 0.189 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 6.466976e-01 | 0.189 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 6.466976e-01 | 0.189 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 6.466976e-01 | 0.189 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 6.473450e-01 | 0.189 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 6.476712e-01 | 0.189 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 6.476712e-01 | 0.189 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 6.481411e-01 | 0.188 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 6.481411e-01 | 0.188 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 6.565906e-01 | 0.183 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 6.581683e-01 | 0.182 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 6.581683e-01 | 0.182 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 6.581683e-01 | 0.182 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 6.581683e-01 | 0.182 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 6.581683e-01 | 0.182 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 6.581683e-01 | 0.182 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 6.581683e-01 | 0.182 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 6.587075e-01 | 0.181 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 6.587075e-01 | 0.181 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 6.587075e-01 | 0.181 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 6.602446e-01 | 0.180 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 6.602446e-01 | 0.180 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 6.679819e-01 | 0.175 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 6.679819e-01 | 0.175 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 6.679819e-01 | 0.175 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 6.679819e-01 | 0.175 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 6.679819e-01 | 0.175 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 6.679819e-01 | 0.175 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 6.679819e-01 | 0.175 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 6.679819e-01 | 0.175 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 6.679819e-01 | 0.175 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 6.679819e-01 | 0.175 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 6.679819e-01 | 0.175 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 6.679819e-01 | 0.175 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 6.679819e-01 | 0.175 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 6.684911e-01 | 0.175 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 6.684911e-01 | 0.175 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 6.692122e-01 | 0.174 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 6.694866e-01 | 0.174 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 6.724521e-01 | 0.172 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 6.734432e-01 | 0.172 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 6.734432e-01 | 0.172 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 6.776554e-01 | 0.169 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 6.776554e-01 | 0.169 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 6.776554e-01 | 0.169 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 6.779238e-01 | 0.169 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 6.794623e-01 | 0.168 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 6.858256e-01 | 0.164 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 6.858256e-01 | 0.164 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 6.882389e-01 | 0.162 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 6.882389e-01 | 0.162 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 6.891835e-01 | 0.162 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 6.891835e-01 | 0.162 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 6.891835e-01 | 0.162 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 6.891835e-01 | 0.162 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 6.891835e-01 | 0.162 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 6.943963e-01 | 0.158 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 6.943963e-01 | 0.158 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 6.943963e-01 | 0.158 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 6.967467e-01 | 0.157 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 6.971396e-01 | 0.157 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 6.971396e-01 | 0.157 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 6.971396e-01 | 0.157 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 6.971396e-01 | 0.157 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 6.971396e-01 | 0.157 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 6.971396e-01 | 0.157 | 0 | 0 |
| Arachidonate production from DAG | R-HSA-426048 | 6.971396e-01 | 0.157 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 6.971396e-01 | 0.157 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 6.971396e-01 | 0.157 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 6.971396e-01 | 0.157 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 6.971396e-01 | 0.157 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 6.972768e-01 | 0.157 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 6.973721e-01 | 0.157 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 6.988247e-01 | 0.156 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 6.988247e-01 | 0.156 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 6.988247e-01 | 0.156 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 7.025534e-01 | 0.153 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 7.081530e-01 | 0.150 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 7.088000e-01 | 0.149 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 7.088000e-01 | 0.149 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 7.104712e-01 | 0.148 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 7.104712e-01 | 0.148 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 7.104712e-01 | 0.148 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 7.104712e-01 | 0.148 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 7.163867e-01 | 0.145 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 7.163867e-01 | 0.145 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 7.225575e-01 | 0.141 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 7.236922e-01 | 0.140 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 7.237383e-01 | 0.140 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 7.237383e-01 | 0.140 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 7.237383e-01 | 0.140 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 7.237383e-01 | 0.140 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 7.237383e-01 | 0.140 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 7.237383e-01 | 0.140 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 7.237383e-01 | 0.140 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 7.237383e-01 | 0.140 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 7.244221e-01 | 0.140 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 7.258869e-01 | 0.139 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 7.258869e-01 | 0.139 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 7.258869e-01 | 0.139 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 7.258869e-01 | 0.139 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 7.258869e-01 | 0.139 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 7.258869e-01 | 0.139 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 7.273700e-01 | 0.138 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 7.273700e-01 | 0.138 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 7.273700e-01 | 0.138 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 7.273700e-01 | 0.138 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 7.273700e-01 | 0.138 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 7.277411e-01 | 0.138 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 7.297404e-01 | 0.137 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 7.297404e-01 | 0.137 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 7.297404e-01 | 0.137 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 7.314252e-01 | 0.136 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 7.355599e-01 | 0.133 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 7.406522e-01 | 0.130 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 7.406522e-01 | 0.130 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 7.406522e-01 | 0.130 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 7.406522e-01 | 0.130 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 7.426174e-01 | 0.129 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 7.449259e-01 | 0.128 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 7.449259e-01 | 0.128 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 7.449259e-01 | 0.128 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 7.449259e-01 | 0.128 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 7.480024e-01 | 0.126 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 7.484337e-01 | 0.126 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 7.525709e-01 | 0.123 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 7.530669e-01 | 0.123 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 7.547781e-01 | 0.122 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 7.547781e-01 | 0.122 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 7.547781e-01 | 0.122 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 7.547781e-01 | 0.122 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 7.547781e-01 | 0.122 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 7.547781e-01 | 0.122 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 7.550222e-01 | 0.122 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 7.581688e-01 | 0.120 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 7.581688e-01 | 0.120 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 7.581688e-01 | 0.120 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 7.615027e-01 | 0.118 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 7.615027e-01 | 0.118 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 7.615027e-01 | 0.118 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 7.615027e-01 | 0.118 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 7.615027e-01 | 0.118 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 7.682772e-01 | 0.114 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 7.682772e-01 | 0.114 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 7.682772e-01 | 0.114 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 7.689150e-01 | 0.114 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 7.689150e-01 | 0.114 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 7.701367e-01 | 0.113 | 0 | 0 |
| Maple Syrup Urine Disease | R-HSA-9865114 | 7.701367e-01 | 0.113 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 7.701367e-01 | 0.113 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 7.701367e-01 | 0.113 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 7.701367e-01 | 0.113 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 7.701367e-01 | 0.113 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 7.701367e-01 | 0.113 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 7.701367e-01 | 0.113 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 7.701367e-01 | 0.113 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 7.701367e-01 | 0.113 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 7.701367e-01 | 0.113 | 0 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 7.701367e-01 | 0.113 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 7.701367e-01 | 0.113 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 7.701367e-01 | 0.113 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 7.768753e-01 | 0.110 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 7.771367e-01 | 0.110 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 7.771367e-01 | 0.110 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 7.792938e-01 | 0.108 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 7.811636e-01 | 0.107 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 7.894648e-01 | 0.103 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 7.903280e-01 | 0.102 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 7.903280e-01 | 0.102 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 7.903280e-01 | 0.102 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 7.903280e-01 | 0.102 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 7.903280e-01 | 0.102 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 7.903280e-01 | 0.102 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 7.903280e-01 | 0.102 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 7.903280e-01 | 0.102 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 7.918658e-01 | 0.101 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 7.918658e-01 | 0.101 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 7.918658e-01 | 0.101 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 7.918658e-01 | 0.101 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 7.918658e-01 | 0.101 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 7.934527e-01 | 0.100 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 7.934527e-01 | 0.100 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 7.934527e-01 | 0.100 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 7.993958e-01 | 0.097 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 8.000470e-01 | 0.097 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 8.023817e-01 | 0.096 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 8.049291e-01 | 0.094 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 8.057282e-01 | 0.094 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 8.057282e-01 | 0.094 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 8.057282e-01 | 0.094 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 8.086477e-01 | 0.092 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 8.087468e-01 | 0.092 | 0 | 0 |
| BCKDH synthesizes BCAA-CoA from KIC, KMVA, KIV | R-HSA-9859138 | 8.087468e-01 | 0.092 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 8.087468e-01 | 0.092 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 8.087468e-01 | 0.092 | 0 | 0 |
| Synthesis of IPs in the nucleus | R-HSA-1855191 | 8.087468e-01 | 0.092 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 8.087468e-01 | 0.092 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 8.087468e-01 | 0.092 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 8.087468e-01 | 0.092 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.087468e-01 | 0.092 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 8.101947e-01 | 0.091 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 8.163048e-01 | 0.088 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 8.163048e-01 | 0.088 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 8.163048e-01 | 0.088 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 8.163048e-01 | 0.088 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 8.172329e-01 | 0.088 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 8.187624e-01 | 0.087 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 8.187624e-01 | 0.087 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 8.187624e-01 | 0.087 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 8.187624e-01 | 0.087 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 8.190118e-01 | 0.087 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 8.199176e-01 | 0.086 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 8.236396e-01 | 0.084 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 8.255486e-01 | 0.083 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 8.255486e-01 | 0.083 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 8.255486e-01 | 0.083 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 8.255486e-01 | 0.083 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 8.255486e-01 | 0.083 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 8.255486e-01 | 0.083 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 8.255486e-01 | 0.083 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 8.255486e-01 | 0.083 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 8.255987e-01 | 0.083 | 0 | 0 |
| Protein folding | R-HSA-391251 | 8.255987e-01 | 0.083 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 8.292260e-01 | 0.081 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 8.310070e-01 | 0.080 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 8.310070e-01 | 0.080 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 8.310070e-01 | 0.080 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 8.408752e-01 | 0.075 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 8.408752e-01 | 0.075 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 8.408752e-01 | 0.075 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 8.408752e-01 | 0.075 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 8.408752e-01 | 0.075 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 8.408752e-01 | 0.075 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 8.408752e-01 | 0.075 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 8.408752e-01 | 0.075 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 8.408752e-01 | 0.075 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 8.408752e-01 | 0.075 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 8.408752e-01 | 0.075 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 8.425000e-01 | 0.074 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 8.425000e-01 | 0.074 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 8.465322e-01 | 0.072 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 8.475965e-01 | 0.072 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 8.481148e-01 | 0.072 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 8.497482e-01 | 0.071 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 8.497482e-01 | 0.071 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 8.497482e-01 | 0.071 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 8.507341e-01 | 0.070 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 8.548561e-01 | 0.068 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 8.548561e-01 | 0.068 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 8.548561e-01 | 0.068 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 8.548561e-01 | 0.068 | 0 | 0 |
| Heme assimilation | R-HSA-9927020 | 8.548561e-01 | 0.068 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 8.548561e-01 | 0.068 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 8.548561e-01 | 0.068 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 8.548561e-01 | 0.068 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 8.548561e-01 | 0.068 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 8.556012e-01 | 0.068 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 8.556012e-01 | 0.068 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 8.556012e-01 | 0.068 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 8.556012e-01 | 0.068 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 8.616621e-01 | 0.065 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 8.625357e-01 | 0.064 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 8.633807e-01 | 0.064 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 8.641978e-01 | 0.063 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 8.641978e-01 | 0.063 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 8.641978e-01 | 0.063 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 8.641978e-01 | 0.063 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 8.641978e-01 | 0.063 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 8.676094e-01 | 0.062 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 8.676094e-01 | 0.062 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 8.676094e-01 | 0.062 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 8.676094e-01 | 0.062 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 8.676094e-01 | 0.062 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 8.676094e-01 | 0.062 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 8.699394e-01 | 0.061 | 1 | 1 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 8.723407e-01 | 0.059 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 8.723407e-01 | 0.059 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 8.723407e-01 | 0.059 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 8.728408e-01 | 0.059 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 8.792428e-01 | 0.056 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 8.792428e-01 | 0.056 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 8.792428e-01 | 0.056 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 8.792428e-01 | 0.056 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 8.792428e-01 | 0.056 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 8.792428e-01 | 0.056 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 8.811424e-01 | 0.055 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 8.816941e-01 | 0.055 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 8.816941e-01 | 0.055 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 8.825226e-01 | 0.054 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 8.837205e-01 | 0.054 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 8.839708e-01 | 0.054 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 8.839708e-01 | 0.054 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 8.898546e-01 | 0.051 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 8.898546e-01 | 0.051 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 8.898546e-01 | 0.051 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 8.898546e-01 | 0.051 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 8.898546e-01 | 0.051 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 8.898546e-01 | 0.051 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 8.898546e-01 | 0.051 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 8.899741e-01 | 0.051 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 8.901216e-01 | 0.051 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 8.905625e-01 | 0.050 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 8.942312e-01 | 0.049 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 8.950513e-01 | 0.048 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 8.950513e-01 | 0.048 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 8.995344e-01 | 0.046 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 8.995344e-01 | 0.046 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 8.995344e-01 | 0.046 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 8.995344e-01 | 0.046 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 8.995344e-01 | 0.046 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.003030e-01 | 0.046 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.004502e-01 | 0.046 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.007420e-01 | 0.045 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 9.028100e-01 | 0.044 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.041859e-01 | 0.044 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.049424e-01 | 0.043 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.049424e-01 | 0.043 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.049424e-01 | 0.043 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 9.056061e-01 | 0.043 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 9.063297e-01 | 0.043 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.068165e-01 | 0.042 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.068889e-01 | 0.042 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 9.083641e-01 | 0.042 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 9.083641e-01 | 0.042 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 9.083641e-01 | 0.042 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 9.083641e-01 | 0.042 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.102328e-01 | 0.041 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 9.126890e-01 | 0.040 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 9.127352e-01 | 0.040 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 9.164182e-01 | 0.038 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.164182e-01 | 0.038 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.164182e-01 | 0.038 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 9.164182e-01 | 0.038 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.179894e-01 | 0.037 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 9.230289e-01 | 0.035 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 9.237649e-01 | 0.034 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 9.237649e-01 | 0.034 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 9.237649e-01 | 0.034 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 9.237649e-01 | 0.034 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 9.237649e-01 | 0.034 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.237649e-01 | 0.034 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.261585e-01 | 0.033 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.268721e-01 | 0.033 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 9.268721e-01 | 0.033 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.271389e-01 | 0.033 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.281697e-01 | 0.032 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.281697e-01 | 0.032 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 9.293378e-01 | 0.032 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 9.293378e-01 | 0.032 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.293378e-01 | 0.032 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.293378e-01 | 0.032 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.304662e-01 | 0.031 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 9.304662e-01 | 0.031 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 9.304662e-01 | 0.031 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 9.304662e-01 | 0.031 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.304662e-01 | 0.031 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 9.304662e-01 | 0.031 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.304662e-01 | 0.031 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.312771e-01 | 0.031 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.318987e-01 | 0.031 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.360550e-01 | 0.029 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 9.365788e-01 | 0.028 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.365788e-01 | 0.028 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 9.365788e-01 | 0.028 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 9.365788e-01 | 0.028 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.365788e-01 | 0.028 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.368984e-01 | 0.028 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.370442e-01 | 0.028 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.391899e-01 | 0.027 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.405529e-01 | 0.027 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 9.421544e-01 | 0.026 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.421544e-01 | 0.026 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.421544e-01 | 0.026 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.421544e-01 | 0.026 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 9.421544e-01 | 0.026 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.436126e-01 | 0.025 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 9.436167e-01 | 0.025 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.448956e-01 | 0.025 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.459037e-01 | 0.024 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.472401e-01 | 0.024 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 9.472401e-01 | 0.024 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 9.472401e-01 | 0.024 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 9.472401e-01 | 0.024 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 9.472401e-01 | 0.024 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.484707e-01 | 0.023 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.484707e-01 | 0.023 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 9.491184e-01 | 0.023 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.508023e-01 | 0.022 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 9.515559e-01 | 0.022 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.515559e-01 | 0.022 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.515559e-01 | 0.022 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 9.518790e-01 | 0.021 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 9.518790e-01 | 0.021 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 9.518790e-01 | 0.021 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.518790e-01 | 0.021 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 9.518790e-01 | 0.021 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.518790e-01 | 0.021 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 9.519779e-01 | 0.021 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 9.532553e-01 | 0.021 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 9.532553e-01 | 0.021 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.551140e-01 | 0.020 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 9.551152e-01 | 0.020 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.561102e-01 | 0.019 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 9.561102e-01 | 0.019 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 9.561102e-01 | 0.019 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.561102e-01 | 0.019 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.567275e-01 | 0.019 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 9.579406e-01 | 0.019 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.584233e-01 | 0.018 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.591672e-01 | 0.018 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 9.599696e-01 | 0.018 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 9.599696e-01 | 0.018 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.608675e-01 | 0.017 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.614970e-01 | 0.017 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.628048e-01 | 0.016 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 9.634569e-01 | 0.016 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 9.634899e-01 | 0.016 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.634899e-01 | 0.016 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 9.636726e-01 | 0.016 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 9.643519e-01 | 0.016 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 9.667008e-01 | 0.015 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 9.667008e-01 | 0.015 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.667008e-01 | 0.015 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.667008e-01 | 0.015 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.670027e-01 | 0.015 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.671393e-01 | 0.015 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.677165e-01 | 0.014 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.696333e-01 | 0.013 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.702229e-01 | 0.013 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.713409e-01 | 0.013 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.717462e-01 | 0.012 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.717462e-01 | 0.012 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.717462e-01 | 0.012 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.723007e-01 | 0.012 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 9.723007e-01 | 0.012 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.734926e-01 | 0.012 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.738227e-01 | 0.012 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 9.738642e-01 | 0.012 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.744382e-01 | 0.011 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 9.747371e-01 | 0.011 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.747371e-01 | 0.011 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.769594e-01 | 0.010 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.769594e-01 | 0.010 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 9.769594e-01 | 0.010 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.769594e-01 | 0.010 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.769594e-01 | 0.010 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.769594e-01 | 0.010 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 9.769594e-01 | 0.010 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.774678e-01 | 0.010 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.789863e-01 | 0.009 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.789863e-01 | 0.009 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.789863e-01 | 0.009 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 9.789863e-01 | 0.009 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.790606e-01 | 0.009 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 9.800726e-01 | 0.009 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.809009e-01 | 0.008 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.825212e-01 | 0.008 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.825212e-01 | 0.008 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.825212e-01 | 0.008 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.840591e-01 | 0.007 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.849341e-01 | 0.007 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.849341e-01 | 0.007 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.852992e-01 | 0.006 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.852992e-01 | 0.006 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.853755e-01 | 0.006 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.853755e-01 | 0.006 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.854618e-01 | 0.006 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.854618e-01 | 0.006 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.859046e-01 | 0.006 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 9.860842e-01 | 0.006 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 9.860842e-01 | 0.006 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 9.860842e-01 | 0.006 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 9.860842e-01 | 0.006 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 9.860842e-01 | 0.006 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.863939e-01 | 0.006 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.865430e-01 | 0.006 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.867411e-01 | 0.006 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.871487e-01 | 0.006 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 9.872717e-01 | 0.006 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.875150e-01 | 0.005 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 9.876689e-01 | 0.005 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.879079e-01 | 0.005 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 9.879079e-01 | 0.005 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 9.879922e-01 | 0.005 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 9.886280e-01 | 0.005 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 9.886280e-01 | 0.005 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.889721e-01 | 0.005 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.889721e-01 | 0.005 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.898878e-01 | 0.004 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.899262e-01 | 0.004 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 9.900671e-01 | 0.004 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.906040e-01 | 0.004 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.908279e-01 | 0.004 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.908279e-01 | 0.004 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.916353e-01 | 0.004 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.917352e-01 | 0.004 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.917352e-01 | 0.004 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.920018e-01 | 0.003 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.920539e-01 | 0.003 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.921258e-01 | 0.003 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.934081e-01 | 0.003 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.938618e-01 | 0.003 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.942142e-01 | 0.003 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.942142e-01 | 0.003 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.947237e-01 | 0.002 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.947237e-01 | 0.002 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 9.951023e-01 | 0.002 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.951883e-01 | 0.002 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.953079e-01 | 0.002 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.954255e-01 | 0.002 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.954547e-01 | 0.002 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.963192e-01 | 0.002 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.963508e-01 | 0.002 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.963704e-01 | 0.002 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.964732e-01 | 0.002 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 9.966336e-01 | 0.001 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.966336e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.975127e-01 | 0.001 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.980864e-01 | 0.001 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.980864e-01 | 0.001 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.982550e-01 | 0.001 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.984019e-01 | 0.001 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.984088e-01 | 0.001 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.984526e-01 | 0.001 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.986510e-01 | 0.001 | 0 | 0 |
| Classical antibody-mediated complement activation | R-HSA-173623 | 9.986892e-01 | 0.001 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.987216e-01 | 0.001 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.987216e-01 | 0.001 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.988979e-01 | 0.000 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.988998e-01 | 0.000 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.989788e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.989968e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.989968e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.990095e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.990834e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.990852e-01 | 0.000 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.990852e-01 | 0.000 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.991357e-01 | 0.000 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.992394e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.992394e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.993065e-01 | 0.000 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.993065e-01 | 0.000 | 0 | 0 |
| Metal ion assimilation from the host | R-HSA-9638482 | 9.993065e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.993065e-01 | 0.000 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.993816e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.994190e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.994234e-01 | 0.000 | 0 | 0 |
| Transport of vitamins, nucleosides, and related molecules | R-HSA-425397 | 9.994742e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.994742e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.995090e-01 | 0.000 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.995206e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.995641e-01 | 0.000 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.996265e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.996349e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.996686e-01 | 0.000 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.996845e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.997387e-01 | 0.000 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.997518e-01 | 0.000 | 0 | 0 |
| Creation of C4 and C2 activators | R-HSA-166786 | 9.997751e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.997842e-01 | 0.000 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.997933e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.997951e-01 | 0.000 | 1 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.998724e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.998781e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.998906e-01 | 0.000 | 0 | 0 |
| Initial triggering of complement | R-HSA-166663 | 9.998953e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.998992e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999022e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999478e-01 | 0.000 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.999518e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999566e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.999619e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999727e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999747e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999773e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999811e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.999852e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999857e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.999873e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999874e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999888e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999936e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999960e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999961e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.999967e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999974e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999977e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999990e-01 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.999993e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999993e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999994e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999995e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999995e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999998e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999999e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999999e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 1 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 1 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 3.463896e-14 | 13.460 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.575406e-13 | 12.803 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.486589e-13 | 12.828 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 3.627099e-13 | 12.440 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.552980e-12 | 11.809 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 6.131939e-11 | 10.212 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.397412e-10 | 9.855 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.764974e-09 | 8.753 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 4.122816e-09 | 8.385 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 4.718014e-09 | 8.326 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 2.877242e-08 | 7.541 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 4.517401e-08 | 7.345 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 5.006500e-08 | 7.300 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 8.861840e-08 | 7.052 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.412172e-07 | 6.850 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 2.503640e-07 | 6.601 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 3.254708e-07 | 6.487 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 3.748969e-07 | 6.426 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 4.797428e-07 | 6.319 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 8.924673e-07 | 6.049 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 8.924673e-07 | 6.049 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.289708e-06 | 5.890 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 3.206255e-06 | 5.494 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 3.237606e-06 | 5.490 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 5.541117e-06 | 5.256 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 5.604516e-06 | 5.251 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 6.138181e-06 | 5.212 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 6.449039e-06 | 5.191 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 7.023493e-06 | 5.153 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 8.461691e-06 | 5.073 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.079690e-05 | 4.967 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.112156e-05 | 4.954 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 1.206324e-05 | 4.919 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.370386e-05 | 4.863 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.528829e-05 | 4.816 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 1.584730e-05 | 4.800 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.719261e-05 | 4.765 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.952730e-05 | 4.709 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.952730e-05 | 4.709 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 2.091485e-05 | 4.680 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 2.293464e-05 | 4.640 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 3.152140e-05 | 4.501 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 3.245931e-05 | 4.489 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 3.381664e-05 | 4.471 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 3.576163e-05 | 4.447 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 3.872133e-05 | 4.412 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 3.767219e-05 | 4.424 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 5.542726e-05 | 4.256 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 5.663467e-05 | 4.247 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 5.911815e-05 | 4.228 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 6.438443e-05 | 4.191 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 6.233018e-05 | 4.205 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 6.617471e-05 | 4.179 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 8.217901e-05 | 4.085 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 8.217901e-05 | 4.085 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 9.768826e-05 | 4.010 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 9.768826e-05 | 4.010 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.007746e-04 | 3.997 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.011924e-04 | 3.995 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.054119e-04 | 3.977 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 1.159395e-04 | 3.936 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.150509e-04 | 3.939 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 1.337061e-04 | 3.874 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 1.329013e-04 | 3.876 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.322805e-04 | 3.879 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.487638e-04 | 3.828 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.517363e-04 | 3.819 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 1.554539e-04 | 3.808 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.577926e-04 | 3.802 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 1.668943e-04 | 3.778 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.692685e-04 | 3.771 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.764899e-04 | 3.753 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 2.095043e-04 | 3.679 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 2.123318e-04 | 3.673 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 2.137219e-04 | 3.670 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 2.563448e-04 | 3.591 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 2.774434e-04 | 3.557 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 3.252631e-04 | 3.488 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 3.252631e-04 | 3.488 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 3.290410e-04 | 3.483 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 3.204833e-04 | 3.494 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 3.290410e-04 | 3.483 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 3.628543e-04 | 3.440 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 3.628543e-04 | 3.440 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 3.695547e-04 | 3.432 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 3.645505e-04 | 3.438 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 3.934508e-04 | 3.405 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 3.995384e-04 | 3.398 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 4.228549e-04 | 3.374 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 4.336577e-04 | 3.363 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 4.324063e-04 | 3.364 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 4.474237e-04 | 3.349 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 4.947749e-04 | 3.306 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 5.361579e-04 | 3.271 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 5.326712e-04 | 3.274 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 5.361692e-04 | 3.271 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 5.678551e-04 | 3.246 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 6.363997e-04 | 3.196 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 6.732179e-04 | 3.172 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 7.012620e-04 | 3.154 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 7.289500e-04 | 3.137 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 8.157859e-04 | 3.088 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 8.301242e-04 | 3.081 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 8.308033e-04 | 3.081 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 8.427693e-04 | 3.074 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 9.152014e-04 | 3.038 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 9.097703e-04 | 3.041 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 9.135762e-04 | 3.039 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 9.580807e-04 | 3.019 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 9.738368e-04 | 3.012 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 9.794195e-04 | 3.009 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 9.836906e-04 | 3.007 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 9.887054e-04 | 3.005 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 9.988550e-04 | 3.000 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.045453e-03 | 2.981 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 1.043298e-03 | 2.982 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.075371e-03 | 2.968 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.085522e-03 | 2.964 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 1.089587e-03 | 2.963 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.091583e-03 | 2.962 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.143915e-03 | 2.942 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.451099e-03 | 2.838 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.451099e-03 | 2.838 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.419705e-03 | 2.848 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 1.522048e-03 | 2.818 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 1.438980e-03 | 2.842 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 1.438980e-03 | 2.842 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 1.547684e-03 | 2.810 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.380210e-03 | 2.860 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.314176e-03 | 2.881 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.314176e-03 | 2.881 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 1.419705e-03 | 2.848 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 1.419705e-03 | 2.848 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.419705e-03 | 2.848 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 1.482816e-03 | 2.829 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.321090e-03 | 2.879 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 1.419705e-03 | 2.848 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.419705e-03 | 2.848 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.600656e-03 | 2.796 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 1.611715e-03 | 2.793 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 1.808054e-03 | 2.743 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 1.817617e-03 | 2.740 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.928643e-03 | 2.715 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 2.040693e-03 | 2.690 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 2.044650e-03 | 2.689 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 2.052674e-03 | 2.688 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 2.108046e-03 | 2.676 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 2.360433e-03 | 2.627 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 2.360433e-03 | 2.627 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 2.309955e-03 | 2.636 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 2.410386e-03 | 2.618 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 2.406399e-03 | 2.619 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 2.282697e-03 | 2.642 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 2.480874e-03 | 2.605 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 2.728815e-03 | 2.564 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 2.738081e-03 | 2.563 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 2.780369e-03 | 2.556 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 2.830730e-03 | 2.548 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 2.830730e-03 | 2.548 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 2.832472e-03 | 2.548 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 2.985924e-03 | 2.525 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 3.014158e-03 | 2.521 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 3.189658e-03 | 2.496 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 3.189658e-03 | 2.496 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 3.285948e-03 | 2.483 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 3.285948e-03 | 2.483 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 3.313655e-03 | 2.480 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 3.760300e-03 | 2.425 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 3.549395e-03 | 2.450 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 3.641560e-03 | 2.439 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 3.515321e-03 | 2.454 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 3.641560e-03 | 2.439 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 3.854865e-03 | 2.414 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 3.854865e-03 | 2.414 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 3.854865e-03 | 2.414 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 3.854865e-03 | 2.414 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 3.979842e-03 | 2.400 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 4.051331e-03 | 2.392 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 4.233185e-03 | 2.373 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 4.265552e-03 | 2.370 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 4.317458e-03 | 2.365 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 4.317458e-03 | 2.365 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 4.317458e-03 | 2.365 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 4.317458e-03 | 2.365 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 5.078653e-03 | 2.294 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 4.905504e-03 | 2.309 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 5.005224e-03 | 2.301 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 5.244973e-03 | 2.280 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 5.244973e-03 | 2.280 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 5.078653e-03 | 2.294 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 5.087351e-03 | 2.294 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 5.244973e-03 | 2.280 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 5.244973e-03 | 2.280 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 4.854482e-03 | 2.314 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 5.254255e-03 | 2.279 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 5.584108e-03 | 2.253 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 5.584108e-03 | 2.253 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 5.584108e-03 | 2.253 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 5.747465e-03 | 2.241 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 5.919063e-03 | 2.228 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 6.086185e-03 | 2.216 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 6.290238e-03 | 2.201 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 6.364186e-03 | 2.196 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 6.364186e-03 | 2.196 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 6.364186e-03 | 2.196 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 6.372943e-03 | 2.196 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 6.772753e-03 | 2.169 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 6.772753e-03 | 2.169 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 6.772753e-03 | 2.169 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 6.818351e-03 | 2.166 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 7.704925e-03 | 2.113 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 7.704925e-03 | 2.113 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 7.719819e-03 | 2.112 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 7.719819e-03 | 2.112 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 7.719819e-03 | 2.112 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 7.207799e-03 | 2.142 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 8.179585e-03 | 2.087 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 8.179585e-03 | 2.087 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 7.719819e-03 | 2.112 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 7.103302e-03 | 2.149 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 7.766228e-03 | 2.110 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 8.284875e-03 | 2.082 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 8.390358e-03 | 2.076 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 8.390358e-03 | 2.076 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 8.397106e-03 | 2.076 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 8.397106e-03 | 2.076 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 8.990000e-03 | 2.046 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 9.093681e-03 | 2.041 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 9.293676e-03 | 2.032 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.322690e-03 | 2.030 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.322690e-03 | 2.030 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 9.341589e-03 | 2.030 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 9.341589e-03 | 2.030 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 9.341589e-03 | 2.030 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 9.397990e-03 | 2.027 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 9.707092e-03 | 2.013 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 9.707092e-03 | 2.013 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 9.830267e-03 | 2.007 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 9.920358e-03 | 2.003 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 9.955976e-03 | 2.002 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 9.955976e-03 | 2.002 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 1.023602e-02 | 1.990 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.023602e-02 | 1.990 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 1.037025e-02 | 1.984 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 1.099777e-02 | 1.959 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 1.121738e-02 | 1.950 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 1.121738e-02 | 1.950 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 1.147507e-02 | 1.940 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.269371e-02 | 1.896 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 1.133514e-02 | 1.946 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 1.283911e-02 | 1.891 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 1.283911e-02 | 1.891 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 1.287214e-02 | 1.890 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.247784e-02 | 1.904 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 1.322857e-02 | 1.878 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.121895e-02 | 1.950 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 1.131802e-02 | 1.946 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 1.121895e-02 | 1.950 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 1.121738e-02 | 1.950 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 1.121738e-02 | 1.950 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 1.283911e-02 | 1.891 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.209511e-02 | 1.917 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 1.337265e-02 | 1.874 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 1.349694e-02 | 1.870 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 1.369480e-02 | 1.863 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 1.369480e-02 | 1.863 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 1.407028e-02 | 1.852 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 1.408784e-02 | 1.851 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 1.416068e-02 | 1.849 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.416623e-02 | 1.849 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.416623e-02 | 1.849 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 1.471532e-02 | 1.832 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 1.471532e-02 | 1.832 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 1.502957e-02 | 1.823 | 0 | 0 |
| PKA activation | R-HSA-163615 | 1.512529e-02 | 1.820 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 1.512529e-02 | 1.820 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 1.512529e-02 | 1.820 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 1.525927e-02 | 1.816 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 1.537653e-02 | 1.813 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 1.537653e-02 | 1.813 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 1.537653e-02 | 1.813 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 1.537653e-02 | 1.813 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 1.537653e-02 | 1.813 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 1.548975e-02 | 1.810 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 1.548975e-02 | 1.810 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 1.548975e-02 | 1.810 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 1.623916e-02 | 1.789 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.623916e-02 | 1.789 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 1.820916e-02 | 1.740 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 1.897411e-02 | 1.722 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.897411e-02 | 1.722 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 1.944661e-02 | 1.711 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 1.573520e-02 | 1.803 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.573520e-02 | 1.803 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 1.752290e-02 | 1.756 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 1.752290e-02 | 1.756 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 1.632283e-02 | 1.787 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 1.736243e-02 | 1.760 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 1.736243e-02 | 1.760 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.581459e-02 | 1.801 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 1.736271e-02 | 1.760 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 1.623916e-02 | 1.789 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.640392e-02 | 1.785 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.710628e-02 | 1.767 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.570307e-02 | 1.804 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.897411e-02 | 1.722 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.897411e-02 | 1.722 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 1.736243e-02 | 1.760 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.862857e-02 | 1.730 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.869786e-02 | 1.728 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.602084e-02 | 1.795 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.570307e-02 | 1.804 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 1.623916e-02 | 1.789 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.576876e-02 | 1.802 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 1.613730e-02 | 1.792 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.579237e-02 | 1.802 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 1.573520e-02 | 1.803 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.800543e-02 | 1.745 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 1.945760e-02 | 1.711 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 1.968831e-02 | 1.706 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 1.976132e-02 | 1.704 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 1.980370e-02 | 1.703 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 2.019029e-02 | 1.695 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 2.019029e-02 | 1.695 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 2.019029e-02 | 1.695 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 2.019029e-02 | 1.695 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 2.028169e-02 | 1.693 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 2.039413e-02 | 1.690 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 2.039413e-02 | 1.690 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 2.039413e-02 | 1.690 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 2.039413e-02 | 1.690 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 2.039413e-02 | 1.690 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 2.039413e-02 | 1.690 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 2.039458e-02 | 1.690 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 2.043408e-02 | 1.690 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 2.043408e-02 | 1.690 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 2.107281e-02 | 1.676 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 2.107281e-02 | 1.676 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 2.107281e-02 | 1.676 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 2.140954e-02 | 1.669 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 2.140954e-02 | 1.669 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 2.140954e-02 | 1.669 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 2.140954e-02 | 1.669 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 2.149405e-02 | 1.668 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 2.168817e-02 | 1.664 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 2.170828e-02 | 1.663 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 2.277488e-02 | 1.643 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 2.631140e-02 | 1.580 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 2.561116e-02 | 1.592 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 2.483757e-02 | 1.605 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 2.328594e-02 | 1.633 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 2.879515e-02 | 1.541 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 2.605343e-02 | 1.584 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 2.939419e-02 | 1.532 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 2.564503e-02 | 1.591 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 2.561116e-02 | 1.592 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 2.411852e-02 | 1.618 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 2.406170e-02 | 1.619 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 2.483757e-02 | 1.605 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 2.640640e-02 | 1.578 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 2.803543e-02 | 1.552 | 1 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 2.852092e-02 | 1.545 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 2.762252e-02 | 1.559 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 2.472223e-02 | 1.607 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 2.980620e-02 | 1.526 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 2.980620e-02 | 1.526 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.576870e-02 | 1.589 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 2.959044e-02 | 1.529 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 2.980620e-02 | 1.526 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 2.328594e-02 | 1.633 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 2.640640e-02 | 1.578 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 2.640640e-02 | 1.578 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 2.980620e-02 | 1.526 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 2.640640e-02 | 1.578 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 2.472223e-02 | 1.607 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 2.472223e-02 | 1.607 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 2.522492e-02 | 1.598 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 2.985992e-02 | 1.525 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 2.872875e-02 | 1.542 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 2.996774e-02 | 1.523 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 2.996774e-02 | 1.523 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 2.996774e-02 | 1.523 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.996774e-02 | 1.523 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 2.996774e-02 | 1.523 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 2.996774e-02 | 1.523 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 3.010333e-02 | 1.521 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 3.020799e-02 | 1.520 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 3.036800e-02 | 1.518 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 3.115232e-02 | 1.507 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 3.172402e-02 | 1.499 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 3.196261e-02 | 1.495 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 3.196261e-02 | 1.495 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 3.196261e-02 | 1.495 | 0 | 0 |
| Protein folding | R-HSA-391251 | 3.199945e-02 | 1.495 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 3.199945e-02 | 1.495 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 3.255699e-02 | 1.487 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 3.255699e-02 | 1.487 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 3.255699e-02 | 1.487 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 3.255699e-02 | 1.487 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 3.267938e-02 | 1.486 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 3.315676e-02 | 1.479 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 3.315676e-02 | 1.479 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 3.349530e-02 | 1.475 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 3.349530e-02 | 1.475 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 3.450832e-02 | 1.462 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 3.478317e-02 | 1.459 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 3.562334e-02 | 1.448 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 3.562334e-02 | 1.448 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 3.578670e-02 | 1.446 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 3.593800e-02 | 1.444 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 3.664945e-02 | 1.436 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 3.695729e-02 | 1.432 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 3.695729e-02 | 1.432 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 3.701146e-02 | 1.432 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 3.748283e-02 | 1.426 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 3.748283e-02 | 1.426 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 3.748283e-02 | 1.426 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 3.764568e-02 | 1.424 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 4.646336e-02 | 1.333 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 4.646336e-02 | 1.333 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 4.646336e-02 | 1.333 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 4.646336e-02 | 1.333 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 4.646336e-02 | 1.333 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 4.646336e-02 | 1.333 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 4.646336e-02 | 1.333 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 4.646336e-02 | 1.333 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 4.646336e-02 | 1.333 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 4.646336e-02 | 1.333 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 4.646336e-02 | 1.333 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 4.646336e-02 | 1.333 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 5.523126e-02 | 1.258 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 5.210173e-02 | 1.283 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 4.173189e-02 | 1.380 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 4.173189e-02 | 1.380 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 5.885851e-02 | 1.230 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 5.243656e-02 | 1.280 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 5.243656e-02 | 1.280 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 5.243656e-02 | 1.280 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 5.837891e-02 | 1.234 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 4.087322e-02 | 1.389 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 4.499825e-02 | 1.347 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 3.941558e-02 | 1.404 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 4.704949e-02 | 1.327 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 5.121556e-02 | 1.291 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 5.121556e-02 | 1.291 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 4.879103e-02 | 1.312 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 5.642133e-02 | 1.249 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 5.116878e-02 | 1.291 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 4.638499e-02 | 1.334 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 5.679204e-02 | 1.246 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 5.243656e-02 | 1.280 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 5.885851e-02 | 1.230 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 5.885851e-02 | 1.230 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 4.189848e-02 | 1.378 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 4.189848e-02 | 1.378 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 5.217915e-02 | 1.283 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 4.908204e-02 | 1.309 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 4.173189e-02 | 1.380 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 4.233223e-02 | 1.373 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 4.727979e-02 | 1.325 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 5.210173e-02 | 1.283 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 4.173189e-02 | 1.380 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 4.704949e-02 | 1.327 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 4.097696e-02 | 1.387 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 4.189848e-02 | 1.378 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 3.943451e-02 | 1.404 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 4.233223e-02 | 1.373 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 4.433134e-02 | 1.353 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 3.941558e-02 | 1.404 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 5.121556e-02 | 1.291 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 5.243656e-02 | 1.280 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 4.173189e-02 | 1.380 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 4.939219e-02 | 1.306 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 5.210173e-02 | 1.283 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 4.503234e-02 | 1.346 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 3.953513e-02 | 1.403 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 4.559305e-02 | 1.341 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 5.679204e-02 | 1.246 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 4.097696e-02 | 1.387 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 4.674499e-02 | 1.330 | 1 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 5.642242e-02 | 1.249 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 5.523126e-02 | 1.258 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 5.837891e-02 | 1.234 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 4.499825e-02 | 1.347 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 5.444517e-02 | 1.264 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 5.210173e-02 | 1.283 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 4.879103e-02 | 1.312 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 4.440290e-02 | 1.353 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 4.968460e-02 | 1.304 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 4.968460e-02 | 1.304 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 5.786333e-02 | 1.238 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 4.318053e-02 | 1.365 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 4.007067e-02 | 1.397 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 4.968460e-02 | 1.304 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 4.968460e-02 | 1.304 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 5.251236e-02 | 1.280 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 5.656647e-02 | 1.247 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 5.656647e-02 | 1.247 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 5.600306e-02 | 1.252 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 5.900573e-02 | 1.229 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 6.026634e-02 | 1.220 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 6.107914e-02 | 1.214 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 6.128263e-02 | 1.213 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 6.142527e-02 | 1.212 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 6.214920e-02 | 1.207 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 6.214920e-02 | 1.207 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 6.214920e-02 | 1.207 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 6.340877e-02 | 1.198 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 6.340877e-02 | 1.198 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 6.472005e-02 | 1.189 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 6.472005e-02 | 1.189 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 6.472005e-02 | 1.189 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 6.515745e-02 | 1.186 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 6.515745e-02 | 1.186 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 6.527199e-02 | 1.185 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 6.611382e-02 | 1.180 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 6.611382e-02 | 1.180 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 6.611382e-02 | 1.180 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 6.806429e-02 | 1.167 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 6.815005e-02 | 1.167 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 6.871981e-02 | 1.163 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 6.871981e-02 | 1.163 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 6.871981e-02 | 1.163 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 6.871981e-02 | 1.163 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 6.917810e-02 | 1.160 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 6.917810e-02 | 1.160 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 6.974417e-02 | 1.156 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 6.997237e-02 | 1.155 | 0 | 0 |
| Translation | R-HSA-72766 | 7.111428e-02 | 1.148 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 7.146202e-02 | 1.146 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 7.286999e-02 | 1.137 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 7.299146e-02 | 1.137 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 7.299146e-02 | 1.137 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 7.299146e-02 | 1.137 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 7.386760e-02 | 1.132 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 7.386760e-02 | 1.132 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 7.386760e-02 | 1.132 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 7.417365e-02 | 1.130 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 7.417365e-02 | 1.130 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 7.417365e-02 | 1.130 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 7.431360e-02 | 1.129 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 7.431360e-02 | 1.129 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 7.510849e-02 | 1.124 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 7.510849e-02 | 1.124 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 7.860518e-02 | 1.105 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 7.860518e-02 | 1.105 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 7.860518e-02 | 1.105 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 7.873310e-02 | 1.104 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 8.089790e-02 | 1.092 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 8.089790e-02 | 1.092 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 8.147361e-02 | 1.089 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 8.148104e-02 | 1.089 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 8.148104e-02 | 1.089 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 8.148104e-02 | 1.089 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 8.148104e-02 | 1.089 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 8.148104e-02 | 1.089 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 8.173225e-02 | 1.088 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 8.173225e-02 | 1.088 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 8.183276e-02 | 1.087 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 8.211723e-02 | 1.086 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 8.211723e-02 | 1.086 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 8.211723e-02 | 1.086 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 8.383162e-02 | 1.077 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 8.383162e-02 | 1.077 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 8.400151e-02 | 1.076 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 8.413918e-02 | 1.075 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 8.454250e-02 | 1.073 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 8.454250e-02 | 1.073 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 8.454250e-02 | 1.073 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 8.454250e-02 | 1.073 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 8.454250e-02 | 1.073 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 8.579031e-02 | 1.067 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 8.614826e-02 | 1.065 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 8.675444e-02 | 1.062 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 8.781681e-02 | 1.056 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 8.781681e-02 | 1.056 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 8.883878e-02 | 1.051 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 8.903399e-02 | 1.050 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 9.051679e-02 | 1.043 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 9.085757e-02 | 1.042 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.335144e-02 | 1.030 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 9.370852e-02 | 1.028 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 9.370852e-02 | 1.028 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 9.370852e-02 | 1.028 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 9.385882e-02 | 1.028 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 9.385882e-02 | 1.028 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 9.385882e-02 | 1.028 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 9.385882e-02 | 1.028 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 9.385882e-02 | 1.028 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 9.385882e-02 | 1.028 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 9.408842e-02 | 1.026 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 9.411820e-02 | 1.026 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 9.506887e-02 | 1.022 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 9.714284e-02 | 1.013 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 9.737425e-02 | 1.012 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 9.900932e-02 | 1.004 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 9.975725e-02 | 1.001 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 1.000811e-01 | 1.000 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 1.003957e-01 | 0.998 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.012136e-01 | 0.995 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.012136e-01 | 0.995 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 1.012136e-01 | 0.995 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 1.015974e-01 | 0.993 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 1.024212e-01 | 0.990 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 1.035138e-01 | 0.985 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 1.050164e-01 | 0.979 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.057800e-01 | 0.976 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 1.070666e-01 | 0.970 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 1.070666e-01 | 0.970 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.082581e-01 | 0.966 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.567888e-01 | 0.805 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.567888e-01 | 0.805 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.567888e-01 | 0.805 | 0 | 0 |
| Defective ACTH causes obesity and POMCD | R-HSA-5579031 | 1.567888e-01 | 0.805 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.567888e-01 | 0.805 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.567888e-01 | 0.805 | 0 | 0 |
| SARS-CoV-1 targets PDZ proteins in cell-cell junction | R-HSA-9692912 | 1.567888e-01 | 0.805 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 1.567888e-01 | 0.805 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 1.567888e-01 | 0.805 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 1.208349e-01 | 0.918 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 1.495831e-01 | 0.825 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 1.795073e-01 | 0.746 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 1.379922e-01 | 0.860 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.379922e-01 | 0.860 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 2.102237e-01 | 0.677 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 2.102237e-01 | 0.677 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 2.102237e-01 | 0.677 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 2.102237e-01 | 0.677 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 1.578476e-01 | 0.802 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 1.578476e-01 | 0.802 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.578476e-01 | 0.802 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 1.578476e-01 | 0.802 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 1.578476e-01 | 0.802 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 1.578476e-01 | 0.802 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 1.578476e-01 | 0.802 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 1.578476e-01 | 0.802 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 1.357884e-01 | 0.867 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 1.357884e-01 | 0.867 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 1.672387e-01 | 0.777 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 1.672387e-01 | 0.777 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 1.542729e-01 | 0.812 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 1.305422e-01 | 0.884 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 1.111407e-01 | 0.954 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 1.111407e-01 | 0.954 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 1.111407e-01 | 0.954 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.105611e-01 | 0.956 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 1.395387e-01 | 0.855 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.321665e-01 | 0.879 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 2.157982e-01 | 0.666 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 1.936624e-01 | 0.713 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 1.207213e-01 | 0.918 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 1.935947e-01 | 0.713 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 2.112950e-01 | 0.675 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 1.896431e-01 | 0.722 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 1.799672e-01 | 0.745 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 1.799672e-01 | 0.745 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 1.798149e-01 | 0.745 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 1.123593e-01 | 0.949 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.415798e-01 | 0.849 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 1.521963e-01 | 0.818 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 1.838465e-01 | 0.736 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 1.202395e-01 | 0.920 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.785112e-01 | 0.748 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 2.053816e-01 | 0.687 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 2.173618e-01 | 0.663 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 2.185326e-01 | 0.660 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 1.578476e-01 | 0.802 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 1.542729e-01 | 0.812 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 1.936624e-01 | 0.713 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 1.711492e-01 | 0.767 | 0 | 0 |
| Microbial factors inhibit CASP4 activity | R-HSA-9956593 | 1.785112e-01 | 0.748 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 1.589136e-01 | 0.799 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 1.379922e-01 | 0.860 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 1.578476e-01 | 0.802 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 1.542729e-01 | 0.812 | 1 | 1 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 1.956444e-01 | 0.709 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 1.305422e-01 | 0.884 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 1.239119e-01 | 0.907 | 0 | 0 |
| Pyrophosphate hydrolysis | R-HSA-71737 | 1.208349e-01 | 0.918 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 1.102411e-01 | 0.958 | 1 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 1.828511e-01 | 0.738 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 1.208349e-01 | 0.918 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.578476e-01 | 0.802 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 1.795073e-01 | 0.746 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 1.795073e-01 | 0.746 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 1.963663e-01 | 0.707 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 1.317832e-01 | 0.880 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 1.432115e-01 | 0.844 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 1.458997e-01 | 0.836 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 2.037928e-01 | 0.691 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 1.567888e-01 | 0.805 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 1.208349e-01 | 0.918 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 1.795073e-01 | 0.746 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 1.190718e-01 | 0.924 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 1.210595e-01 | 0.917 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 1.357884e-01 | 0.867 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 1.415798e-01 | 0.849 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.602335e-01 | 0.795 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 1.404876e-01 | 0.852 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 2.053816e-01 | 0.687 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.357884e-01 | 0.867 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 1.998580e-01 | 0.699 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 1.199363e-01 | 0.921 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 1.766238e-01 | 0.753 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 1.822207e-01 | 0.739 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 1.848468e-01 | 0.733 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 1.101480e-01 | 0.958 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 1.681357e-01 | 0.774 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 1.453606e-01 | 0.838 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 1.495831e-01 | 0.825 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 1.795073e-01 | 0.746 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 1.199363e-01 | 0.921 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 1.273414e-01 | 0.895 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.321665e-01 | 0.879 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.579062e-01 | 0.802 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.579062e-01 | 0.802 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 1.285631e-01 | 0.891 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 1.920907e-01 | 0.716 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 1.297088e-01 | 0.887 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 2.185326e-01 | 0.660 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 1.795073e-01 | 0.746 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.672387e-01 | 0.777 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 1.199363e-01 | 0.921 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 1.199363e-01 | 0.921 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 1.838465e-01 | 0.736 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 2.025836e-01 | 0.693 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 1.848468e-01 | 0.733 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 1.768694e-01 | 0.752 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 2.084818e-01 | 0.681 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 1.672387e-01 | 0.777 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 1.998580e-01 | 0.699 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 1.888871e-01 | 0.724 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 2.185326e-01 | 0.660 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.131170e-01 | 0.946 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 2.102237e-01 | 0.677 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 2.102237e-01 | 0.677 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.202395e-01 | 0.920 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 1.455364e-01 | 0.837 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 1.956313e-01 | 0.709 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 1.471893e-01 | 0.832 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 2.025836e-01 | 0.693 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 1.432360e-01 | 0.844 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 1.578476e-01 | 0.802 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 1.578476e-01 | 0.802 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 1.578476e-01 | 0.802 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 1.357884e-01 | 0.867 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 1.838465e-01 | 0.736 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 1.822207e-01 | 0.739 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 2.042804e-01 | 0.690 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 1.838465e-01 | 0.736 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 1.785112e-01 | 0.748 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 1.963663e-01 | 0.707 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 2.185326e-01 | 0.660 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.848468e-01 | 0.733 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 1.998580e-01 | 0.699 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 1.998580e-01 | 0.699 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 1.998580e-01 | 0.699 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 1.432360e-01 | 0.844 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 1.210595e-01 | 0.917 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 1.672387e-01 | 0.777 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 1.329006e-01 | 0.876 | 0 | 0 |
| Assembly of Viral Components at the Budding Site | R-HSA-168316 | 1.208349e-01 | 0.918 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 2.217667e-01 | 0.654 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 2.217667e-01 | 0.654 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 2.217667e-01 | 0.654 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 2.217667e-01 | 0.654 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 2.234880e-01 | 0.651 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 2.257146e-01 | 0.646 | 0 | 0 |
| Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN) | R-HSA-5619039 | 2.257146e-01 | 0.646 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 2.257146e-01 | 0.646 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.257146e-01 | 0.646 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 2.257146e-01 | 0.646 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 2.257146e-01 | 0.646 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 2.257146e-01 | 0.646 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 2.257146e-01 | 0.646 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 2.263877e-01 | 0.645 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 2.263877e-01 | 0.645 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 2.263877e-01 | 0.645 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 2.292966e-01 | 0.640 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 2.302343e-01 | 0.638 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 2.364915e-01 | 0.626 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 2.364915e-01 | 0.626 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.364915e-01 | 0.626 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 2.364915e-01 | 0.626 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 2.393246e-01 | 0.621 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 2.397769e-01 | 0.620 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 2.414031e-01 | 0.617 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 2.414031e-01 | 0.617 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 2.414031e-01 | 0.617 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 2.414031e-01 | 0.617 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 2.414031e-01 | 0.617 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 2.418793e-01 | 0.616 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 2.430543e-01 | 0.614 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 2.430543e-01 | 0.614 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 2.430543e-01 | 0.614 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 2.430543e-01 | 0.614 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 2.433666e-01 | 0.614 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 2.441208e-01 | 0.612 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 2.441208e-01 | 0.612 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 2.441208e-01 | 0.612 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 2.441208e-01 | 0.612 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 2.449309e-01 | 0.611 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 2.475257e-01 | 0.606 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 2.481269e-01 | 0.605 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 2.485863e-01 | 0.605 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 2.547820e-01 | 0.594 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 2.566861e-01 | 0.591 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 2.674608e-01 | 0.573 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 2.704487e-01 | 0.568 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 2.712477e-01 | 0.567 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 2.727649e-01 | 0.564 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 2.727649e-01 | 0.564 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 2.727649e-01 | 0.564 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 2.727649e-01 | 0.564 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 2.727649e-01 | 0.564 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 2.727649e-01 | 0.564 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 2.736424e-01 | 0.563 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 2.736424e-01 | 0.563 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 2.742877e-01 | 0.562 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 2.856333e-01 | 0.544 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 2.880103e-01 | 0.541 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 2.890099e-01 | 0.539 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 2.890099e-01 | 0.539 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 2.890099e-01 | 0.539 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 2.890099e-01 | 0.539 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.897278e-01 | 0.538 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.897278e-01 | 0.538 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.897278e-01 | 0.538 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 2.897278e-01 | 0.538 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 2.898414e-01 | 0.538 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 2.898414e-01 | 0.538 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 2.921267e-01 | 0.534 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 2.921267e-01 | 0.534 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 2.921267e-01 | 0.534 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 2.921267e-01 | 0.534 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 2.923284e-01 | 0.534 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 2.937283e-01 | 0.532 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 2.953854e-01 | 0.530 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 3.001778e-01 | 0.523 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 3.001778e-01 | 0.523 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 3.033313e-01 | 0.518 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 3.034194e-01 | 0.518 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 3.040711e-01 | 0.517 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 3.040711e-01 | 0.517 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 3.040711e-01 | 0.517 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 3.040711e-01 | 0.517 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 3.062043e-01 | 0.514 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 3.062043e-01 | 0.514 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 3.110692e-01 | 0.507 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 3.127783e-01 | 0.505 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 3.127783e-01 | 0.505 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 3.127783e-01 | 0.505 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 3.127783e-01 | 0.505 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 3.190708e-01 | 0.496 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 3.196212e-01 | 0.495 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 3.204501e-01 | 0.494 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 3.241448e-01 | 0.489 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 3.241448e-01 | 0.489 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 3.290618e-01 | 0.483 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 3.290618e-01 | 0.483 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 3.290618e-01 | 0.483 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 3.295158e-01 | 0.482 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 3.301207e-01 | 0.481 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 3.351216e-01 | 0.475 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 3.351216e-01 | 0.475 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 3.351216e-01 | 0.475 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 3.351216e-01 | 0.475 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 3.351216e-01 | 0.475 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 3.351216e-01 | 0.475 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 3.351216e-01 | 0.475 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 3.358700e-01 | 0.474 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 3.358700e-01 | 0.474 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 3.358700e-01 | 0.474 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 3.358700e-01 | 0.474 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 3.358700e-01 | 0.474 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 3.358700e-01 | 0.474 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 3.366604e-01 | 0.473 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 3.392829e-01 | 0.469 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 3.394751e-01 | 0.469 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 3.445171e-01 | 0.463 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 3.471346e-01 | 0.460 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 3.471346e-01 | 0.460 | 0 | 0 |
| Signalling to STAT3 | R-HSA-198745 | 3.471346e-01 | 0.460 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 3.471346e-01 | 0.460 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 3.471346e-01 | 0.460 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 3.492303e-01 | 0.457 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 3.492303e-01 | 0.457 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 3.589190e-01 | 0.445 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 3.589190e-01 | 0.445 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 3.589190e-01 | 0.445 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 3.589190e-01 | 0.445 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 3.589990e-01 | 0.445 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 3.657490e-01 | 0.437 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 3.657490e-01 | 0.437 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 3.657490e-01 | 0.437 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 3.657490e-01 | 0.437 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 3.657490e-01 | 0.437 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 3.657490e-01 | 0.437 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 3.657490e-01 | 0.437 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 3.683500e-01 | 0.434 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 3.683500e-01 | 0.434 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 3.725973e-01 | 0.429 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 3.726088e-01 | 0.429 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 3.726088e-01 | 0.429 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 3.726088e-01 | 0.429 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 3.726088e-01 | 0.429 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 3.737566e-01 | 0.427 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 3.749014e-01 | 0.426 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 3.749014e-01 | 0.426 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 3.798144e-01 | 0.420 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 3.818489e-01 | 0.418 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 3.818489e-01 | 0.418 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 3.886189e-01 | 0.410 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 3.887509e-01 | 0.410 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 3.958151e-01 | 0.403 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 3.958151e-01 | 0.403 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 3.958151e-01 | 0.403 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 3.958151e-01 | 0.403 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 3.958151e-01 | 0.403 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 4.005106e-01 | 0.397 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 4.005106e-01 | 0.397 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 4.005106e-01 | 0.397 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 4.005106e-01 | 0.397 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 4.005106e-01 | 0.397 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 4.005106e-01 | 0.397 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 4.005106e-01 | 0.397 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 4.005106e-01 | 0.397 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 4.005106e-01 | 0.397 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 4.043902e-01 | 0.393 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 4.043902e-01 | 0.393 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 4.043902e-01 | 0.393 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 4.064399e-01 | 0.391 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 4.064399e-01 | 0.391 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 4.103954e-01 | 0.387 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 4.127894e-01 | 0.384 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 4.160586e-01 | 0.381 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 4.176069e-01 | 0.379 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 4.193424e-01 | 0.377 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 4.225157e-01 | 0.374 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 4.252072e-01 | 0.371 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 4.252072e-01 | 0.371 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 4.252072e-01 | 0.371 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 4.252072e-01 | 0.371 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 4.252072e-01 | 0.371 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 4.252072e-01 | 0.371 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 4.253270e-01 | 0.371 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 4.253270e-01 | 0.371 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 4.253270e-01 | 0.371 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 4.270792e-01 | 0.369 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 4.270792e-01 | 0.369 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 4.270792e-01 | 0.369 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 4.288380e-01 | 0.368 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 4.342462e-01 | 0.362 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 4.353335e-01 | 0.361 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 4.390152e-01 | 0.358 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 4.413784e-01 | 0.355 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 4.440582e-01 | 0.353 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 4.440582e-01 | 0.353 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 4.492608e-01 | 0.348 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 4.495257e-01 | 0.347 | 0 | 0 |
| IRS activation | R-HSA-74713 | 4.495257e-01 | 0.347 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 4.495257e-01 | 0.347 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 4.495257e-01 | 0.347 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 4.495257e-01 | 0.347 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 4.495257e-01 | 0.347 | 0 | 0 |
| PTK6 Activates STAT3 | R-HSA-8849474 | 4.495257e-01 | 0.347 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 4.495257e-01 | 0.347 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 4.495257e-01 | 0.347 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 4.495257e-01 | 0.347 | 0 | 0 |
| Toxicity of botulinum toxin type G (botG) | R-HSA-5250989 | 4.495257e-01 | 0.347 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 4.495257e-01 | 0.347 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 4.495257e-01 | 0.347 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 4.495257e-01 | 0.347 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 4.495257e-01 | 0.347 | 0 | 0 |
| Zinc efflux and compartmentalization by the SLC30 family | R-HSA-435368 | 4.495257e-01 | 0.347 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 4.508593e-01 | 0.346 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 4.538344e-01 | 0.343 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 4.538344e-01 | 0.343 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 4.538344e-01 | 0.343 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 4.550113e-01 | 0.342 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 4.554031e-01 | 0.342 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 4.614263e-01 | 0.336 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 4.614263e-01 | 0.336 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 4.625667e-01 | 0.335 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 4.625667e-01 | 0.335 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 4.625990e-01 | 0.335 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 4.625990e-01 | 0.335 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 4.625990e-01 | 0.335 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 4.625990e-01 | 0.335 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 4.634755e-01 | 0.334 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 4.638314e-01 | 0.334 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 4.691450e-01 | 0.329 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 4.705088e-01 | 0.327 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 4.710848e-01 | 0.327 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 4.710848e-01 | 0.327 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 4.710848e-01 | 0.327 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 4.710848e-01 | 0.327 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 4.716555e-01 | 0.326 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 4.716555e-01 | 0.326 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 4.716555e-01 | 0.326 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 4.760317e-01 | 0.322 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 4.807420e-01 | 0.318 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 4.809177e-01 | 0.318 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 4.816255e-01 | 0.317 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 4.816255e-01 | 0.317 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 4.816255e-01 | 0.317 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 4.816255e-01 | 0.317 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 4.817052e-01 | 0.317 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 4.877502e-01 | 0.312 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 4.885168e-01 | 0.311 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 4.917909e-01 | 0.308 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 4.917909e-01 | 0.308 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 4.925077e-01 | 0.308 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 4.925077e-01 | 0.308 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 4.925077e-01 | 0.308 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 4.925077e-01 | 0.308 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 4.945360e-01 | 0.306 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 4.945360e-01 | 0.306 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 4.945360e-01 | 0.306 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 4.945360e-01 | 0.306 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 4.945360e-01 | 0.306 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 4.945360e-01 | 0.306 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 4.945360e-01 | 0.306 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 4.945360e-01 | 0.306 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 4.945360e-01 | 0.306 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 4.945360e-01 | 0.306 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 4.945360e-01 | 0.306 | 0 | 0 |
| Orexin and neuropeptides FF and QRFP bind to their respective receptors | R-HSA-389397 | 4.945360e-01 | 0.306 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 4.945360e-01 | 0.306 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 4.945360e-01 | 0.306 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 4.947864e-01 | 0.306 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 4.959178e-01 | 0.305 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 4.972836e-01 | 0.303 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 4.989853e-01 | 0.302 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 4.989853e-01 | 0.302 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 5.040939e-01 | 0.297 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 5.073867e-01 | 0.295 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 5.085259e-01 | 0.294 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 5.085259e-01 | 0.294 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 5.085259e-01 | 0.294 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 5.085259e-01 | 0.294 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 5.085259e-01 | 0.294 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 5.085259e-01 | 0.294 | 0 | 0 |
| Virus Assembly and Release | R-HSA-168268 | 5.085259e-01 | 0.294 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 5.134915e-01 | 0.289 | 0 | 0 |
| Immune System | R-HSA-168256 | 5.151385e-01 | 0.288 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 5.193844e-01 | 0.285 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 5.193844e-01 | 0.285 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 5.216215e-01 | 0.283 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 5.216215e-01 | 0.283 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 5.216215e-01 | 0.283 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 5.216215e-01 | 0.283 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 5.216215e-01 | 0.283 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 5.216215e-01 | 0.283 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 5.216215e-01 | 0.283 | 1 | 1 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 5.236171e-01 | 0.281 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 5.302134e-01 | 0.276 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 5.310868e-01 | 0.275 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 5.340037e-01 | 0.272 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 5.340037e-01 | 0.272 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 5.342650e-01 | 0.272 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 5.344954e-01 | 0.272 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 5.344954e-01 | 0.272 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 5.344954e-01 | 0.272 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 5.344954e-01 | 0.272 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 5.344954e-01 | 0.272 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 5.344954e-01 | 0.272 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 5.344954e-01 | 0.272 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 5.358684e-01 | 0.271 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 5.358684e-01 | 0.271 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 5.358684e-01 | 0.271 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 5.358684e-01 | 0.271 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 5.358684e-01 | 0.271 | 0 | 0 |
| Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT) | R-HSA-5619070 | 5.358684e-01 | 0.271 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 5.358684e-01 | 0.271 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 5.358684e-01 | 0.271 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 5.358684e-01 | 0.271 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 5.358684e-01 | 0.271 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 5.358684e-01 | 0.271 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 5.365890e-01 | 0.270 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 5.384476e-01 | 0.269 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 5.404726e-01 | 0.267 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 5.501574e-01 | 0.260 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 5.514325e-01 | 0.259 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 5.514325e-01 | 0.259 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 5.514325e-01 | 0.259 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 5.514325e-01 | 0.259 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 5.540167e-01 | 0.256 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 5.540167e-01 | 0.256 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 5.540167e-01 | 0.256 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 5.540167e-01 | 0.256 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 5.540167e-01 | 0.256 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 5.595064e-01 | 0.252 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 5.595064e-01 | 0.252 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 5.595064e-01 | 0.252 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 5.595064e-01 | 0.252 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 5.607481e-01 | 0.251 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 5.682594e-01 | 0.245 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 5.704543e-01 | 0.244 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 5.707537e-01 | 0.244 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 5.730752e-01 | 0.242 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 5.735079e-01 | 0.241 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 5.735079e-01 | 0.241 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 5.735079e-01 | 0.241 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 5.738232e-01 | 0.241 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 5.738232e-01 | 0.241 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 5.738232e-01 | 0.241 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 5.738232e-01 | 0.241 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 5.738232e-01 | 0.241 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 5.738232e-01 | 0.241 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 5.738232e-01 | 0.241 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 5.738232e-01 | 0.241 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 5.746005e-01 | 0.241 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 5.746005e-01 | 0.241 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 5.835420e-01 | 0.234 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 5.835420e-01 | 0.234 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 5.835420e-01 | 0.234 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 5.835420e-01 | 0.234 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 5.847297e-01 | 0.233 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 5.924589e-01 | 0.227 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 5.924589e-01 | 0.227 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 5.924589e-01 | 0.227 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 5.924589e-01 | 0.227 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 5.986621e-01 | 0.223 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 6.065946e-01 | 0.217 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 6.065946e-01 | 0.217 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 6.065946e-01 | 0.217 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 6.065946e-01 | 0.217 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 6.065946e-01 | 0.217 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 6.065946e-01 | 0.217 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 6.065946e-01 | 0.217 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 6.086763e-01 | 0.216 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 6.086763e-01 | 0.216 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 6.086763e-01 | 0.216 | 0 | 0 |
| RSK activation | R-HSA-444257 | 6.086763e-01 | 0.216 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 6.086763e-01 | 0.216 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 6.086763e-01 | 0.216 | 0 | 0 |
| Toxicity of botulinum toxin type B (botB) | R-HSA-5250958 | 6.086763e-01 | 0.216 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 6.086763e-01 | 0.216 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 6.086763e-01 | 0.216 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 6.086763e-01 | 0.216 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 6.086763e-01 | 0.216 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 6.086763e-01 | 0.216 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 6.086763e-01 | 0.216 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 6.086763e-01 | 0.216 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 6.086763e-01 | 0.216 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 6.086763e-01 | 0.216 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 6.091172e-01 | 0.215 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 6.120879e-01 | 0.213 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 6.149131e-01 | 0.211 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 6.149131e-01 | 0.211 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 6.165464e-01 | 0.210 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 6.165464e-01 | 0.210 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 6.225627e-01 | 0.206 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 6.286640e-01 | 0.202 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 6.286640e-01 | 0.202 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 6.286640e-01 | 0.202 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 6.286640e-01 | 0.202 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 6.286640e-01 | 0.202 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 6.286640e-01 | 0.202 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 6.286863e-01 | 0.202 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 6.318712e-01 | 0.199 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 6.355198e-01 | 0.197 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 6.406810e-01 | 0.193 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 6.406810e-01 | 0.193 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 6.406810e-01 | 0.193 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 6.406810e-01 | 0.193 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 6.406810e-01 | 0.193 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 6.406810e-01 | 0.193 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 6.406810e-01 | 0.193 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 6.406810e-01 | 0.193 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 6.406810e-01 | 0.193 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 6.406810e-01 | 0.193 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 6.406810e-01 | 0.193 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 6.406810e-01 | 0.193 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 6.406810e-01 | 0.193 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 6.459449e-01 | 0.190 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 6.459449e-01 | 0.190 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 6.467960e-01 | 0.189 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 6.467960e-01 | 0.189 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 6.497569e-01 | 0.187 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 6.555125e-01 | 0.183 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 6.613146e-01 | 0.180 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 6.626266e-01 | 0.179 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 6.698855e-01 | 0.174 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 6.698855e-01 | 0.174 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 6.698855e-01 | 0.174 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 6.700700e-01 | 0.174 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 6.700700e-01 | 0.174 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 6.700700e-01 | 0.174 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 6.700700e-01 | 0.174 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 6.700700e-01 | 0.174 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 6.700700e-01 | 0.174 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 6.700700e-01 | 0.174 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 6.700700e-01 | 0.174 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 6.700700e-01 | 0.174 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 6.700700e-01 | 0.174 | 0 | 0 |
| Peptide hormone biosynthesis | R-HSA-209952 | 6.700700e-01 | 0.174 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 6.700700e-01 | 0.174 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 6.700700e-01 | 0.174 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 6.700700e-01 | 0.174 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 6.743867e-01 | 0.171 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 6.751687e-01 | 0.171 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 6.751687e-01 | 0.171 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 6.754226e-01 | 0.170 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 6.787301e-01 | 0.168 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 6.787301e-01 | 0.168 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 6.890662e-01 | 0.162 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 6.890662e-01 | 0.162 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 6.890662e-01 | 0.162 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 6.890662e-01 | 0.162 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 6.890662e-01 | 0.162 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 6.891172e-01 | 0.162 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 6.942563e-01 | 0.158 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 6.942563e-01 | 0.158 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 6.942563e-01 | 0.158 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 6.962135e-01 | 0.157 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 6.970568e-01 | 0.157 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 6.970568e-01 | 0.157 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 6.970568e-01 | 0.157 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 6.970568e-01 | 0.157 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 6.970568e-01 | 0.157 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 6.970568e-01 | 0.157 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 6.970568e-01 | 0.157 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 6.973866e-01 | 0.157 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 6.995661e-01 | 0.155 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 7.023970e-01 | 0.153 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 7.040034e-01 | 0.152 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 7.073195e-01 | 0.150 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 7.073195e-01 | 0.150 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 7.073195e-01 | 0.150 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 7.092085e-01 | 0.149 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 7.112786e-01 | 0.148 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 7.112786e-01 | 0.148 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 7.218376e-01 | 0.142 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 7.218376e-01 | 0.142 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 7.218376e-01 | 0.142 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 7.218376e-01 | 0.142 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 7.218376e-01 | 0.142 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 7.246687e-01 | 0.140 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 7.246687e-01 | 0.140 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 7.246687e-01 | 0.140 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 7.250922e-01 | 0.140 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 7.277134e-01 | 0.138 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 7.337275e-01 | 0.134 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 7.397535e-01 | 0.131 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 7.403421e-01 | 0.131 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 7.404713e-01 | 0.130 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 7.411396e-01 | 0.130 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 7.411396e-01 | 0.130 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 7.413587e-01 | 0.130 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 7.445928e-01 | 0.128 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 7.445928e-01 | 0.128 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 7.445928e-01 | 0.128 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 7.445928e-01 | 0.128 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 7.445928e-01 | 0.128 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 7.445928e-01 | 0.128 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 7.445928e-01 | 0.128 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 7.445928e-01 | 0.128 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 7.445928e-01 | 0.128 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 7.447458e-01 | 0.128 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 7.506813e-01 | 0.125 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 7.531902e-01 | 0.123 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 7.531902e-01 | 0.123 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 7.531902e-01 | 0.123 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 7.567597e-01 | 0.121 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 7.567597e-01 | 0.121 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 7.634057e-01 | 0.117 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 7.634057e-01 | 0.117 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 7.634057e-01 | 0.117 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 7.650603e-01 | 0.116 | 0 | 0 |
| PDH complex synthesizes acetyl-CoA from PYR | R-HSA-9861559 | 7.654877e-01 | 0.116 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 7.654877e-01 | 0.116 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 7.654877e-01 | 0.116 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 7.654877e-01 | 0.116 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 7.654877e-01 | 0.116 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 7.654877e-01 | 0.116 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 7.688580e-01 | 0.114 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 7.715580e-01 | 0.113 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 7.715580e-01 | 0.113 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 7.735221e-01 | 0.112 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 7.740485e-01 | 0.111 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 7.817575e-01 | 0.107 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 7.819732e-01 | 0.107 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 7.846743e-01 | 0.105 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 7.846743e-01 | 0.105 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 7.846743e-01 | 0.105 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 7.846743e-01 | 0.105 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 7.846743e-01 | 0.105 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 7.846743e-01 | 0.105 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 7.846743e-01 | 0.105 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 7.846743e-01 | 0.105 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 7.872683e-01 | 0.104 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 7.872683e-01 | 0.104 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 7.933585e-01 | 0.101 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 7.988091e-01 | 0.098 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 7.988091e-01 | 0.098 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 7.988091e-01 | 0.098 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 8.009373e-01 | 0.096 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 8.022922e-01 | 0.096 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 8.022922e-01 | 0.096 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 8.022922e-01 | 0.096 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 8.022922e-01 | 0.096 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 8.036013e-01 | 0.095 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 8.043339e-01 | 0.095 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 8.113232e-01 | 0.091 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 8.113232e-01 | 0.091 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 8.113232e-01 | 0.091 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 8.113232e-01 | 0.091 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 8.124698e-01 | 0.090 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 8.129005e-01 | 0.090 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 8.159221e-01 | 0.088 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 8.184696e-01 | 0.087 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 8.184696e-01 | 0.087 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 8.184696e-01 | 0.087 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 8.184696e-01 | 0.087 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 8.184696e-01 | 0.087 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 8.192860e-01 | 0.087 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 8.218359e-01 | 0.085 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 8.218359e-01 | 0.085 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 8.231376e-01 | 0.085 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 8.231376e-01 | 0.085 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 8.269409e-01 | 0.083 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 8.285246e-01 | 0.082 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 8.290065e-01 | 0.081 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 8.304158e-01 | 0.081 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 8.333242e-01 | 0.079 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 8.333242e-01 | 0.079 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 8.333242e-01 | 0.079 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 8.333242e-01 | 0.079 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 8.333242e-01 | 0.079 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 8.333242e-01 | 0.079 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 8.342829e-01 | 0.079 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 8.348967e-01 | 0.078 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 8.369020e-01 | 0.077 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 8.382749e-01 | 0.077 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 8.382749e-01 | 0.077 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 8.382749e-01 | 0.077 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 8.386490e-01 | 0.076 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 8.447894e-01 | 0.073 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 8.465444e-01 | 0.072 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 8.465444e-01 | 0.072 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 8.469640e-01 | 0.072 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 8.469640e-01 | 0.072 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 8.469640e-01 | 0.072 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 8.469640e-01 | 0.072 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 8.469640e-01 | 0.072 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 8.546871e-01 | 0.068 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.546871e-01 | 0.068 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 8.546871e-01 | 0.068 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 8.594747e-01 | 0.066 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 8.594747e-01 | 0.066 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 8.594747e-01 | 0.066 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 8.594884e-01 | 0.066 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 8.594884e-01 | 0.066 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 8.594884e-01 | 0.066 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 8.613583e-01 | 0.065 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 8.635166e-01 | 0.064 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 8.637315e-01 | 0.064 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 8.637315e-01 | 0.064 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 8.640051e-01 | 0.063 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 8.640051e-01 | 0.063 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 8.640051e-01 | 0.063 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.640051e-01 | 0.063 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 8.643834e-01 | 0.063 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 8.682954e-01 | 0.061 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 8.684544e-01 | 0.061 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 8.709884e-01 | 0.060 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 8.709884e-01 | 0.060 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 8.709884e-01 | 0.060 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 8.709884e-01 | 0.060 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 8.709884e-01 | 0.060 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 8.727721e-01 | 0.059 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 8.727721e-01 | 0.059 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 8.780611e-01 | 0.056 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 8.783573e-01 | 0.056 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 8.810157e-01 | 0.055 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 8.812772e-01 | 0.055 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 8.815479e-01 | 0.055 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 8.815479e-01 | 0.055 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 8.815479e-01 | 0.055 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 8.815479e-01 | 0.055 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 8.854979e-01 | 0.053 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 8.887629e-01 | 0.051 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 8.887629e-01 | 0.051 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 8.912437e-01 | 0.050 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 8.912437e-01 | 0.050 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 8.912437e-01 | 0.050 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 8.912437e-01 | 0.050 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 8.912437e-01 | 0.050 | 0 | 0 |
| Vitamin C (ascorbate) metabolism | R-HSA-196836 | 8.912437e-01 | 0.050 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 8.912437e-01 | 0.050 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 8.912437e-01 | 0.050 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 8.914899e-01 | 0.050 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 8.923775e-01 | 0.049 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 8.940794e-01 | 0.049 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 8.940794e-01 | 0.049 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 8.960398e-01 | 0.048 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 8.960398e-01 | 0.048 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 8.960398e-01 | 0.048 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 8.966038e-01 | 0.047 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 9.001464e-01 | 0.046 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 9.001464e-01 | 0.046 | 0 | 0 |
| Androgen biosynthesis | R-HSA-193048 | 9.001464e-01 | 0.046 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.001464e-01 | 0.046 | 0 | 0 |
| Glucocorticoid biosynthesis | R-HSA-194002 | 9.001464e-01 | 0.046 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.001464e-01 | 0.046 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 9.001464e-01 | 0.046 | 0 | 0 |
| Metabolism of Angiotensinogen to Angiotensins | R-HSA-2022377 | 9.001464e-01 | 0.046 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.001464e-01 | 0.046 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.017911e-01 | 0.045 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.028713e-01 | 0.044 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 9.083208e-01 | 0.042 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 9.083208e-01 | 0.042 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 9.083208e-01 | 0.042 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 9.092816e-01 | 0.041 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.093575e-01 | 0.041 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.100447e-01 | 0.041 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.124125e-01 | 0.040 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.131828e-01 | 0.039 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.137608e-01 | 0.039 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.152938e-01 | 0.038 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.157883e-01 | 0.038 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 9.158264e-01 | 0.038 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 9.158264e-01 | 0.038 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 9.209302e-01 | 0.036 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 9.227180e-01 | 0.035 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.227180e-01 | 0.035 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 9.227180e-01 | 0.035 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 9.227180e-01 | 0.035 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 9.227180e-01 | 0.035 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.227180e-01 | 0.035 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.236120e-01 | 0.035 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.243288e-01 | 0.034 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.243288e-01 | 0.034 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 9.261094e-01 | 0.033 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.262119e-01 | 0.033 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 9.274082e-01 | 0.033 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.286271e-01 | 0.032 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 9.290457e-01 | 0.032 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 9.290457e-01 | 0.032 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 9.290457e-01 | 0.032 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 9.290457e-01 | 0.032 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 9.290457e-01 | 0.032 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.290457e-01 | 0.032 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 9.311592e-01 | 0.031 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.345084e-01 | 0.029 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 9.348557e-01 | 0.029 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 9.348557e-01 | 0.029 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.348557e-01 | 0.029 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.358715e-01 | 0.029 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.380710e-01 | 0.028 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.401902e-01 | 0.027 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.401902e-01 | 0.027 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 9.401902e-01 | 0.027 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.401902e-01 | 0.027 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 9.407701e-01 | 0.027 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 9.409658e-01 | 0.026 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.450882e-01 | 0.025 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.450882e-01 | 0.025 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 9.450882e-01 | 0.025 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 9.450882e-01 | 0.025 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 9.450882e-01 | 0.025 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 9.460957e-01 | 0.024 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.462478e-01 | 0.024 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.479777e-01 | 0.023 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.485723e-01 | 0.023 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 9.495854e-01 | 0.022 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 9.495854e-01 | 0.022 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.506243e-01 | 0.022 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.575056e-01 | 0.019 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 9.584559e-01 | 0.018 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.618263e-01 | 0.017 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 9.641823e-01 | 0.016 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 9.641823e-01 | 0.016 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 9.641823e-01 | 0.016 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.641843e-01 | 0.016 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 9.671166e-01 | 0.015 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.675207e-01 | 0.014 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.698107e-01 | 0.013 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.706066e-01 | 0.013 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.723114e-01 | 0.012 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.735381e-01 | 0.012 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.745551e-01 | 0.011 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 9.745551e-01 | 0.011 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.745551e-01 | 0.011 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.745658e-01 | 0.011 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.752854e-01 | 0.011 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.763469e-01 | 0.010 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.766401e-01 | 0.010 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.770049e-01 | 0.010 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.772244e-01 | 0.010 | 0 | 0 |
| tRNA processing in the mitochondrion | R-HSA-6785470 | 9.785544e-01 | 0.009 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 9.785544e-01 | 0.009 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.808272e-01 | 0.008 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.809954e-01 | 0.008 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 9.819254e-01 | 0.008 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.819254e-01 | 0.008 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.823380e-01 | 0.008 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 9.823380e-01 | 0.008 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.825591e-01 | 0.008 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.825591e-01 | 0.008 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.833627e-01 | 0.007 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 9.834069e-01 | 0.007 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 9.834069e-01 | 0.007 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 9.834069e-01 | 0.007 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.847522e-01 | 0.007 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.847669e-01 | 0.007 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.882145e-01 | 0.005 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.882145e-01 | 0.005 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.882145e-01 | 0.005 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.888004e-01 | 0.005 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.895611e-01 | 0.005 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.902230e-01 | 0.004 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.909252e-01 | 0.004 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.910148e-01 | 0.004 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.914227e-01 | 0.004 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.916299e-01 | 0.004 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.923734e-01 | 0.003 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.927094e-01 | 0.003 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.927490e-01 | 0.003 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.929464e-01 | 0.003 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.935249e-01 | 0.003 | 0 | 0 |
| Cytosolic sulfonation of small molecules | R-HSA-156584 | 9.935249e-01 | 0.003 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.942125e-01 | 0.003 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.957831e-01 | 0.002 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.961255e-01 | 0.002 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.968009e-01 | 0.001 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.970032e-01 | 0.001 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.970032e-01 | 0.001 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.971597e-01 | 0.001 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.972491e-01 | 0.001 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.972891e-01 | 0.001 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.973619e-01 | 0.001 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.976821e-01 | 0.001 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.978724e-01 | 0.001 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.980843e-01 | 0.001 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.982073e-01 | 0.001 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.983545e-01 | 0.001 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.983545e-01 | 0.001 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.984896e-01 | 0.001 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.985819e-01 | 0.001 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.986360e-01 | 0.001 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.988242e-01 | 0.001 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.988336e-01 | 0.001 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.990159e-01 | 0.000 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.993233e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.993589e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.993739e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.994209e-01 | 0.000 | 1 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.995712e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.995982e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.996167e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.997042e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.997135e-01 | 0.000 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 9.997352e-01 | 0.000 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 9.997897e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.998067e-01 | 0.000 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 9.998070e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.998494e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.998942e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999011e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999109e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999182e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999312e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999423e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999552e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.999636e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999682e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999708e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999755e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.999950e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999956e-01 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 9.999978e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999987e-01 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 9.999989e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999990e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999998e-01 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 1 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 1 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |